<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD with OASIS Tables v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing-oasis-article1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jpoasis-nisons2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-id journal-id-type="publisher-id">IPHB</journal-id><journal-id journal-id-type="publisher-id">iphb20</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6746293</article-id><article-id pub-id-type="pmid">31500475</article-id><article-id pub-id-type="doi">10.1080/13880209.2019.1656753</article-id><article-id pub-id-type="publisher-id">1656753</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Methanol extracts of <italic>Fagara zanthoxyloides</italic> leaves possess antimalarial effects and normalizes haematological and biochemical status of <italic>Plasmodium berghei</italic>-passaged mice</article-title><alt-title alt-title-type="running-authors">O. C. Enechi et al.</alt-title><alt-title alt-title-type="running-title">Antimalarial Effects of F. Zanthoxiloides Leaves</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Enechi</surname><given-names>Osmund Chukwuma</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Amah</surname><given-names>Christian Chijioke</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9424-7535</contrib-id><name><surname>Okagu</surname><given-names>Innocent Uzochukwu</given-names></name><xref ref-type="aff" rid="AF0001"/><xref ref-type="corresp" rid="AN0001"/></contrib><contrib contrib-type="author"><name><surname>Ononiwu</surname><given-names>Chidinma Pamela</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Azidiegwu</surname><given-names>Vitalis Chukwumalume</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Ugwuoke</surname><given-names>Eberechukwu Ogochukwu</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Onoh</surname><given-names>Amarachukwu Pearl</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><contrib contrib-type="author"><name><surname>Ndukwe</surname><given-names>Emmanuel Elekweuwa</given-names></name><xref ref-type="aff" rid="AF0001"/></contrib><aff id="AF0001"><institution>Department of Biochemistry, University of Nigeria</institution>, Nsukka, <country>Nigeria</country></aff></contrib-group><author-notes><corresp id="AN0001">CONTACT Innocent Uzochukwu Okagu <email>innocent.okagu@unn.edu.ng</email><institution>Medical Parasitology, Toxicology and Drug Discovery Unit, Department of Biochemistry, University of Nigeria</institution>, Nsukka, <country>Nigeria</country></corresp></author-notes><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>9</day><month>9</month><year>2019</year></pub-date><volume>57</volume><issue>1</issue><fpage seq="73">577</fpage><lpage>585</lpage><history><date date-type="received"><day>08</day><month>5</month><year>2019</year></date><date date-type="rev-recd"><day>05</day><month>8</month><year>2019</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>The Author(s)</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IPHB_57_1656753.pdf"/><abstract><title>Abstract</title><p><bold>Context:</bold> The resistance of <italic>Plasmodium</italic> species to many available antimalarials calls for a continuous search for newer antimalarial agents. One possible source of new antimalarials is from natural sources such as <italic>Fagara zanthoxyloides</italic> Lam (Rutaceae), a medicinal plant used traditionally for treating malaria in South-Eastern Nigeria, Uganda and Asia.</p><p><bold>Objectives:</bold> To investigate the application of methanol extracts of <italic>F. zanthoxyloides</italic> in combating malaria infection and its associated disorders.</p><p><bold>Materials and methods:</bold> Methanol extracts of <italic>F</italic>. <italic>zanthoxyloides</italic> leaves (MEFZ) were evaluated for <italic>in vivo</italic> antimalarial activity. MEFZ at doses of 200, 400, and 600&#x02009;mg/kg/d were administered orally for 4 consecutive days (days 0&#x02013;4) to <italic>P. berghei-</italic>infected mice. The possible ameliorative effects of MEFZ on malaria-associated organ malfunctions were also assessed.</p><p><bold>Results:</bold> At 200, 400 and 600&#x02009;mg/kg b.w., respectively, MEFZ produced 82.37% and 68.39%, 84.84%, and 90.75%, 95.95% and 92.67% chemosuppression and inhibition of <italic>P. berghei</italic>, respectively, comparable to 98.67% and 97.29% by combisunate, a standard antimalarial. The IC<sub>50</sub> of MEFZ was estimated to be 235.23&#x02009;mg/kg b.w. Similarly, treatment of parasitized mice with MEFZ significantly restored the malaria-modified haematological and biochemical status of the parasitized-MEFZ-treated mice compared with parasitized-untreated mice. MEFZ was tolerable up to 5000&#x02009;mg/kg b.w dose; hence, the LD<sub>50</sub> is above 5000&#x02009;mg/kg b.w.</p><p><bold>Discussion and conclusions:</bold> The results of this curative assay demonstrated that MEFZ has antimalarial effects and normalized haematological and biochemical aberrations generated by malaria. The isolation of the antimalarial principles in MEFZ is warranted; they could be lead molecules for the development of new antimalarials.</p></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Medicinal plants</kwd><kwd>kidney</kwd><kwd>oxidative stress</kwd><kwd>antioxidants</kwd><kwd>liver</kwd></kwd-group><counts><fig-count count="0"/><table-count count="8"/><page-count count="9"/><word-count count="9168"/></counts></article-meta></front><body><sec id="s0001"><title>Introduction</title><p>Malaria still remains one of the deadliest infectious diseases in the world today, causing high morbidity and mortality annually. It is endemic in tropical and sub-tropical regions including parts of Africa, Asia, and the Americas. In 2015, there were 212 million cases of malaria, leading to 429,000 deaths, most of which were children less than 5&#x02009;years old (World Health Organization [WHO] <xref rid="CIT0098" ref-type="bibr">2016a</xref>). These figures rose to 216 million cases in 2016, resulting in 445,000 deaths, most of which occurred in Sub-Saharan Africa and India (World Health Organization [WHO] <xref rid="CIT0100" ref-type="bibr">2017</xref>). World Health Organization [WHO] (<xref rid="CIT0101" ref-type="bibr">2018</xref>) estimated that about 3.2 billion people across 91 countries are still at risk of malaria. Global Technical Strategy for Malaria sets a target to reduce the case of malaria incidence and mortality rates at least 40% by the year 2020.</p><p>Five species of <italic>Plasmodium</italic> (Plasmodiidae), the causative agent of malaria, are infectious to humans. These species include <italic>P. falciparum, P. vivax, P. malariae,</italic> and <italic>P. ovale.</italic> The other specie called <italic>P. knowlesi</italic> is zoonotic and can be transmitted from animals to humans. <italic>Plasmodium falciparum</italic> is responsible for the vast majority of deaths from malaria especially in unprotected and non-immune populations (Balogun et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2012</xref>; Esan et&#x000a0;al. <xref rid="CIT0028" ref-type="bibr">2014</xref>). However, in malarial studies using rodents, the <italic>P. berghei</italic> is the model frequently adopted because it shares common characteristics with <italic>P. falciparum</italic> (Ogbuehi et&#x000a0;al. <xref rid="CIT0063" ref-type="bibr">2014</xref>).</p><p>The high mortality rate associated with malaria infection, especially in tropical and sub-tropical regions of the world, is of great concern. In addition, several reports document increase in the development and spread of resistance to antimalarials by these parasites (Nuwaha <xref rid="CIT0060" ref-type="bibr">2001</xref>; Dondorp et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2009</xref>; Rogers et&#x000a0;al. <xref rid="CIT0078" ref-type="bibr">2009</xref>; Lun et&#x000a0;al. <xref rid="CIT0051" ref-type="bibr">2014</xref>; Suresh and Haldar <xref rid="CIT0087" ref-type="bibr">2018</xref>) and toxicities associated with conventional antimalarial drugs (Peto <xref rid="CIT0074" ref-type="bibr">1989</xref>; Luzzi and Peto <xref rid="CIT0053" ref-type="bibr">1993</xref>; McGready et&#x000a0;al. <xref rid="CIT0055" ref-type="bibr">2002</xref>; Alkadi <xref rid="CIT0005" ref-type="bibr">2007</xref>; Clark <xref rid="CIT0018" ref-type="bibr">2009</xref>; El-Dakdoky, <xref rid="CIT0024" ref-type="bibr">2009</xref>; Boareto et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2012</xref>; Bitta et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2017</xref>; Luo et&#x000a0;al. <xref rid="CIT0052" ref-type="bibr">2018</xref>) necessitate the search for alternatives especially from natural product such as plants (Lawal et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2015</xref>). Research on plants has increased tremendously due to rising evidence of their medicinal potential (Odeghe et&#x000a0;al. <xref rid="CIT0061" ref-type="bibr">2012</xref>). These health benefits are attributed to their bioactive components that can function individually and synergistically, exhibiting a wide range of biological activities (Kumar et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2011</xref>). These bioactive components can be found in the leaves, seeds, bark, fruits, roots, and flowers of these plants (Osho et&#x000a0;al. <xref rid="CIT0069" ref-type="bibr">2011</xref>).</p><p><italic>Fagara</italic> species (Rutaceae) are deciduous and evergreen shrubs and trees native to warm temperate and subtropical regions of the world (Medhi et&#x000a0;al. <xref rid="CIT0056" ref-type="bibr">2013</xref>), and are widely grown in the rainforest regions of Southern Nigeria. Traditional healers in Nigeria use species of the <italic>Fagara</italic> for the treatment of a wide range of disorders, including toothache, urinary and venereal diseases, rheumatism, and lumbago (Adesina <xref rid="CIT0003" ref-type="bibr">2005</xref>). In Uganda, the plant is widely used for the treatment of malaria and related conditions (Ogwal-Okeng et&#x000a0;al. <xref rid="CIT0064" ref-type="bibr">2003</xref>). Some of the metabolites isolated from <italic>Fagara</italic> species include alkaloids, aliphatic and aromatic amides, lignins, coumarins, and sterols (Adefisoye et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2012</xref>). Some of these metabolites have shown cytotoxic, molluscidal, anticonvulsant, and anti-sickling effects (Sofowora and Isaacs <xref rid="CIT0083" ref-type="bibr">1971</xref>; Honig et&#x000a0;al. <xref rid="CIT0034" ref-type="bibr">1975</xref>; Sofowora et&#x000a0;al., <xref rid="CIT0084" ref-type="bibr">1975</xref>; Abu et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">1981</xref>; Ouattara et&#x000a0;al. <xref rid="CIT0070" ref-type="bibr">2009</xref>). Others include anesthetic, antibacterial (Taiwo et&#x000a0;al. <xref rid="CIT0088" ref-type="bibr">1999</xref>; Ynalvez et&#x000a0;al. <xref rid="CIT0103" ref-type="bibr">2012</xref>), antihypertensive, and anti-inflammatory (Oriowo <xref rid="CIT0067" ref-type="bibr">1982</xref>; Aloke et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2012</xref>) properties. Oyedapo and Famurewa (<xref rid="CIT0071" ref-type="bibr">1995</xref>) demonstrated that extracts of <italic>F. zanthoxyloides</italic> Lam have antiprotease and membrane stabilizing activities. Similarly, the antibacterial and antifungal activities of roots bark were demonstrated (Anne et&#x000a0;al. 2013, Misra et&#x000a0;al. <xref rid="CIT0057" ref-type="bibr">2013</xref>). Antiparasitic activity of root extracts was found to be significantly active against the intracellular form of <italic>Leishmania</italic> major parasite (Maximin et&#x000a0;al. <xref rid="CIT0054" ref-type="bibr">2007</xref>); while leaves extract has presented lowest anthelminthic activities on <italic>Ascaris lumbricoides</italic> (Barnabas et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">2011</xref>). The nonpolar fractions from crude alkaloid displayed a good antiplasmodial effect with an IC<sub>50</sub> ranging from 1.91 to 4.32&#x02009;&#x003bc;g/mL (Gansane et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2010</xref>). The reverse-phase high-pressure liquid chromatography (RP-HPLC)-semipurified, and RP-HPLC-purified root extract inhibit the growth of <italic>P. falciparum</italic> (3D7) <italic>in vitro</italic>, with an IC<sub>50</sub> value of 4.90, 1.00 and 0.13&#x02009;&#x003bc;g/mL, respectively (Kassim et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2005</xref>).</p><p>It is, therefore, necessary to evaluate the antimalarial potentials of <italic>F. zanthoxyloides</italic> in order to scientifically validate the folkloric use of the plant in the management of malaria. It is also believed that a good antimalarial candidate should not only clear malaria parasite but also restores aberrations induced by malaria infection; hence, we monitored the effect of the extract on haematological and biochemical indices of parasitized mice.</p></sec><sec id="s0002"><title>Materials and methods</title><sec id="s0003"><title>Plant materials</title><p>Fresh leaves of <italic>F. zanthoxyloides</italic> were collected in April 2018 from a habitat in Uzo-Uwani Local Government Area of Enugu State, Nigeria. The plant materials were identified and authenticated by Mr Alfred Ozioko, a taxonomist of the Bioresources Development and Conservation Program (BDCP) Research Centre, Nsukka, Enugu State, Nigeria. Voucher specimen with voucher number, #Intercedd/901 was deposited at the herbarium for reference purposes. The authenticity of the identification was also confirmed with that in &#x02018;<ext-link ext-link-type="uri" xlink:href="http://www.theplantlist.org/">http://www.theplantlist.org/</ext-link>&#x02019; and &#x02018;<ext-link ext-link-type="uri" xlink:href="http://www.ipni.org/">http://www.ipni.org/</ext-link>&#x02019; databases. The plant material was washed of dirt and air-dried for 2 weeks with turning at intervals to avoid decaying.</p></sec><sec id="s0004"><title>Study animals</title><p>Fifty-four adult healthy albino Wistar mice of average body weight of 30&#x02009;&#x000b1;&#x02009;5&#x02009;g were used for this study; 24 for the acute toxicity study and 30 for the antimalarial study. They were purchased from the Animal Breeding Unit, Faculty of Veterinary Medicine, University of Nigeria, Nsukka. The mice were acclimatized under standard laboratory condition with 12&#x02009;h light/dark cycle in the Animal Farm of the Department of Biochemistry for 1 week prior to the commencement of the experiment. They were maintained on a regular feed (commercial Rodent Chow, Vital Feeds Nig. Ltd.) and portable water <italic>ad libitum</italic>. They received humane care throughout the experimental period in accordance with the institutional (EC approval number, UNN/FBS/2018_029A), national and international ethical recommendations for care and use of laboratory animals (National Academy of Sciences [NAS] 2011).</p></sec><sec id="s0005"><title>Chemicals and reagents</title><p>All chemicals used in this study were of analytical grade. They were products of Sigma Aldrich, St. Louis, MO (standard phytochemicals, ammonia, sodium hydroxide, ethyl acetate, acetic anhydride, ferric chloride, and formaldehyde), British Drug House (BDH), England (methanol, ethanol, hydrochloric acid, and sulphuric acid), Qualikems, India (citric acid, aluminium chloride, and phosphomolybdic acid), Fluka, Germany (lead acetate and potassium ferrocyanide) and May and Baker, England (sodium chloride, dextrose, and sodium citrate). Reagents used for haematological analysis were products of Sysmex Corporation (Kobe, Japan), kits used for biochemical assays were products of Randox and Roche Diagnostics.</p></sec><sec id="s0006"><title>Standard drug</title><p>The standard antimalarial drug used in this study was combisunate (Ajanta Pharma Ltd., Mumbai, India), an artemisinin-combination therapy (ACT) composed of arthemeter and lumefantrine in a ratio of 80:480. The drug was procured from a reputable retailer, Vegil Pharmaceutical and Drug Stores, Nsukka, Nigeria.</p></sec><sec id="s0007"><title>Extraction procedure</title><p>The dried leaves of the plant were pulverized into a coarse form using a mechanical grinder. Powdered sample (1500&#x02009;g) was macerated in 4.5&#x02009;L of methanol (British Drug House (BDH), England, UK) and the suspension was left standing for 72&#x02009;h with occasional stirring. The suspension was thereafter filtered using a mesh. Further filtration was achieved using Whatman No. 1 filter paper to remove fine residues. The extraction process was repeated twice and all the filtrate was concentrated using a rotary evaporator at 45&#x02009;&#x000b0;C to obtain the crude methanol extract (MEFZ) that was stored in an air-tight container at 4&#x02009;&#x000b0;C until needed.</p></sec><sec id="s0008"><title>Phytochemical analysis of methanol extract of F. zanthoxyloides leaf</title><p>The phytochemical analysis of MEFZ was carried out in order to ascertain the presence of plant secondary metabolites in the extract. This was done using the protocols illustrated by Trease and Evans (<xref rid="CIT0091" ref-type="bibr">1989</xref>) and Harborne (<xref rid="CIT0032" ref-type="bibr">1998</xref>).</p></sec><sec id="s0009"><title>Acute toxicity test</title><p>The acute toxicity profile of the extract was performed in two phases following the method of Lorke (<xref rid="CIT0050" ref-type="bibr">1983</xref>) with slight modification. Briefly, out of the 24 mice to be used in acute toxicity study, 12 mice divided into 3 groups of 4 mice each were used in phase I. Mice in groups 1, 2, and 3 received 10, 100 and 1000&#x02009;mg/kg b.w. of extract, respectively. The mice were monitored for 24&#x02009;h. From the result of phase I, higher doses were chosen for phase II. In this phase, the remaining 12 mice were divided into 3 groups of 4 mice each: mice in groups 4&#x02013;6 received 1600, 2900, and 5000&#x02009;mg/kg b.w. of extract, respectively. The mice were then observed for 24&#x02009;h for lethality or any morphological and behavioural signs of toxicity (dullness, changes in eyes and fur appearance/colour, hyperactivity, changes in feeding patterns, sedation, etc.). Body weight of the mice 24&#x02009;h post-extract administration was measured and compared with the initial body weight.</p></sec><sec id="s0010"><title>Parasite inoculation</title><p>Donor mouse blood infected with the <italic>P. berghei</italic> ANKA-65 obtained from Faculty of Veterinary Medicine, University of Nigeria, Nsukka, Enugu State, Nigeria, was used for inoculum preparation. Blood was drawn from the donor mouse using heart puncture and diluted serially in Alsever&#x02019;s solution to make a suspension containing about 1&#x02009;&#x000d7;&#x02009;10<sup>6</sup> infected RBCs in every 0.2&#x02009;mL suspension. This suspension (0.2&#x02009;mL) was injected into the experimental animals intraperitoneally to initiate infection.</p></sec><sec id="s0011"><title>Experimental design for antimalarial study: a curative assay</title><p>Thirty healthy adult Wistar mice used for this curative assay were divided into six groups of five mice each: group 1 (non-parasitized rats) which served as normal control received vehicle (normal saline). Group 2 (parasite control) was infected with the malaria parasite and was untreated. Group 3 (standard control) was parasitized and treated with 140&#x02009;mg/kg b.w of combisunate. Parasitized mice in groups 4&#x02013;6 were treated with 200, 400, and 600&#x02009;mg/kg b.w. of the extract for 4 consecutive days (day 0&#x02013;day 3), a slight modification of Peters (<xref rid="CIT0073" ref-type="bibr">1965</xref>) method. On the fifth day, after an overnight fast, the mice were euthanized and their blood samples were collected via cardiac puncture. Whole blood from each mouse was used for haematological analysis using Sysmex KX-21N and serum derived from the remaining blood sample was used for analyses of lipid profile, liver function test and serum electrolyte levels in Roche Cobas 6000 chemistry analyzer. In addition, lipid peroxidation status was determined spectrophotometrically by measuring the level of the lipid peroxidation product, malondialdehyde (MDA) based on the method of Wallin et&#x000a0;al. (<xref rid="CIT0097" ref-type="bibr">1993</xref>), and superoxide dismutase (SOD) and catalase (CAT) activities were assayed based on the methods of Xin et&#x000a0;al. (<xref rid="CIT0102" ref-type="bibr">1991</xref>) and Aebi (<xref rid="CIT0004" ref-type="bibr">1983</xref>), respectively. The reduced glutathione concentration was determined based on the method of Kings and Wootton (<xref rid="CIT0044" ref-type="bibr">1959</xref>), all as contained in Randox commercial kits.</p></sec><sec id="s0012"><title>Determination of parasitemia level in experimental animals</title><p>The level of parasitemia in the experimental mice was determined using microscopic techniques (World Health Organization [WHO] <xref rid="CIT0099" ref-type="bibr">2016b</xref>; Bain <xref rid="CIT0008" ref-type="bibr">2017</xref>; Osei-Bimpong and Burthem <xref rid="CIT0068" ref-type="bibr">2017</xref>). Thick blood smears were prepared on days 0 and 3 from tail blood, Giemsa stained and examined under a high-power microscope (&#x000d7;100 oil immersion resolution) to determine the parasitaemia level. The percentage parasitaemia was determined by counting the parasitized red blood cells (RBCs) out of total RBCs in random fields of the microscope using the formula below:
<disp-formula id="M0001"><alternatives><graphic xlink:href="IPHB_A_1656753_M0001.jpg" position="float" orientation="portrait"/><mml:math id="d1e718"><mml:mtext>Percentage&#x000a0;malaria&#x000a0;parasitaemia&#x000a0;</mml:mtext><mml:mo>(</mml:mo><mml:mi mathvariant="normal">%</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>Number&#x000a0;of&#x000a0;parasitized&#x000a0;RBC</mml:mtext></mml:mrow><mml:mrow><mml:mtext>Total&#x000a0;number&#x000a0;of&#x000a0;RBC&#x000a0;counted</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:math></alternatives></disp-formula>
</p><p>The day 3 percentage inhibition and percentage chemosuppression were calculated using the formulas below.
<disp-formula id="M0002"><alternatives><graphic xlink:href="IPHB_A_1656753_M0002.jpg" position="float" orientation="portrait"/><mml:math id="d1e747"><mml:mi mathvariant="normal">Day</mml:mi><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>3</mml:mn><mml:mtext>&#x000a0;Percentage&#x000a0;Inhibition&#x000a0;</mml:mtext><mml:mo>(</mml:mo><mml:mi mathvariant="normal">%</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mtext>MP&#x000a0;of&#x000a0;untreated</mml:mtext><mml:mo>&#x02212;</mml:mo><mml:mtext>MP&#x000a0;of&#x000a0;treated&#x000a0;</mml:mtext></mml:mrow><mml:mrow><mml:mtext>MP&#x000a0;of&#x000a0;untreated</mml:mtext></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:math></alternatives></disp-formula>
<disp-formula id="M0003"><alternatives><graphic xlink:href="IPHB_A_1656753_M0003.jpg" position="float" orientation="portrait"/><mml:math id="d1e783"><mml:mi mathvariant="normal">Day</mml:mi><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>3</mml:mn><mml:mtext>&#x000a0;Malaria&#x000a0;Chemosuppression&#x000a0;</mml:mtext><mml:mo>(</mml:mo><mml:mi mathvariant="normal">%</mml:mi><mml:mo>)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="normal">Day</mml:mi><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>0</mml:mn><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mi mathvariant="normal">MP</mml:mi><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">Day</mml:mi><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>3</mml:mn><mml:mtext>&#x000a0;MP&#x000a0;&#x000a0;</mml:mtext></mml:mrow><mml:mrow><mml:mi mathvariant="normal">Day</mml:mi><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mn>0</mml:mn><mml:mi mathvariant="normal">&#x000a0;</mml:mi><mml:mi mathvariant="normal">MP</mml:mi></mml:mrow></mml:mfrac><mml:mo>&#x000d7;</mml:mo><mml:mn>100</mml:mn></mml:math></alternatives></disp-formula>
where MP is the percentage malaria parasitaemia</p></sec><sec id="s0013"><title>Statistical analysis</title><p>Raw data obtained from the laboratory were analyzed using one-way analysis of variance (ANOVA) to compare means across groups and Student&#x02019;s <italic>t</italic>-test to compare mean body weight during acute toxicity test and parasitemia levels after 4&#x02009;d of MEFZ treatment in Statistical Product and Service Solution (SPSS), version 20.0 (Chicago, IL). The results were presented as mean&#x02009;&#x000b1;&#x02009;SD in tables. Mean values with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 were considered significant.</p></sec></sec><sec id="s0014"><title>Results</title><sec id="s0015"><title>Phytochemical constituents of the extract</title><p>The phytochemical analysis of the extract showed the presence of flavonoid (1592.593&#x02009;&#x000b1;&#x02009;8.903&#x02009;mg/100&#x02009;g), terpenoids (905.297&#x02009;&#x000b1;&#x02009;10.140&#x02009;mg/100&#x02009;g), phenols (699.139&#x02009;&#x000b1;&#x02009;2.607&#x02009;mg/100&#x02009;g), and alkaloids (156.098&#x02009;&#x000b1;&#x02009;4.527&#x02009;mg/100&#x02009;g) in high concentration. However, the presence of glycosides (128.223&#x02009;&#x000b1;&#x02009;0.933&#x02009;mg/100&#x02009;g) and tannins (13.513&#x02009;&#x000b1;&#x02009;1.084&#x02009;mg/100&#x02009;g) was detected in moderate concentrations, while steroids (0.710&#x02009;&#x000b1;&#x02009;0.146&#x02009;mg/100&#x02009;g) and saponins (0.649&#x02009;&#x000b1;&#x02009;0.110&#x02009;mg/100&#x02009;g) were detected in low concentrations (<xref rid="t0001" ref-type="table">Table 1</xref>).</p><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Phytochemical composition of MEFZ.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Phytochemicals constituents</th><th align="center">Concentration (mg/100&#x02009;g)</th></tr></thead><tbody valign="top"><tr><td align="left">Flavonoid</td><td align="char" char=".">1592.593&#x02009;&#x000b1;&#x02009;8.903</td></tr><tr><td align="left">Terpenoids</td><td align="char" char=".">905.297&#x02009;&#x000b1;&#x02009;10.140</td></tr><tr><td align="left">Phenols</td><td align="char" char=".">699.139&#x02009;&#x000b1;&#x02009;2.607</td></tr><tr><td align="left">Alkaloids</td><td align="char" char=".">156.098&#x02009;&#x000b1;&#x02009;4.527</td></tr><tr><td align="left">Glycosides</td><td align="char" char=".">128.223&#x02009;&#x000b1;&#x02009;0.933</td></tr><tr><td align="left">Tannins</td><td align="char" char=".">13.513&#x02009;&#x000b1;&#x02009;1.084</td></tr><tr><td align="left">Steroids</td><td align="char" char=".">0.710&#x02009;&#x000b1;&#x02009;0.146</td></tr><tr><td align="left">Saponins</td><td align="char" char=".">0.649&#x02009;&#x000b1;&#x02009;0.110</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Results are expressed in mean&#x02009;&#x000b1;&#x02009;SD of triplicate determinations.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0016"><title>Acute toxicity profile of the MEFZ</title><p>The result of an acute toxicity test showed that MEFZ was not lethal even at the highest dosage (5000&#x02009;mg/kg body weight) administered. There was no significant behavioural change within 24&#x02009;h of acute toxicity study. Similarly, there was no significant change in body weight of the mice 24&#x02009;h post-extract administration in both phases of the study (<xref rid="t0002" ref-type="table">Table 2</xref>). These suggest that the lethality dose is above 5000&#x02009;mg/kg body weight.</p><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Acute toxicity profile of the MEFZ.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Groups</th><th rowspan="2" align="center">Mortality</th><th rowspan="2" align="center">Behavioral changes</th><th colspan="2" align="center">Body weight (g)<hr/></th></tr><tr><th align="center">Pre-treatment</th><th align="center">Post-treatment</th></tr></thead><tbody valign="top"><tr><td colspan="5">Phase I</td></tr><tr><td align="left">&#x02003;Group 1</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">27.88&#x02009;&#x000b1;&#x02009;1.42<sup>a</sup></td><td align="char" char=".">27.92&#x02009;&#x000b1;&#x02009;2.91<sup>a</sup></td></tr><tr><td align="left">&#x02003;Group 2</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">32.90&#x02009;&#x000b1;&#x02009;1.33<sup>a</sup></td><td align="char" char=".">32.95&#x02009;&#x000b1;&#x02009;1.03<sup>a</sup></td></tr><tr><td align="left">&#x02003;Group 3</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">32.20&#x02009;&#x000b1;&#x02009;1.53<sup>a</sup></td><td align="char" char=".">32.13&#x02009;&#x000b1;&#x02009;1.20<sup>a</sup></td></tr><tr><td colspan="5">Phase II</td></tr><tr><td align="left">&#x02003;Group 4</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">28.65&#x02009;&#x000b1;&#x02009;1.33<sup>a</sup></td><td align="char" char=".">29.08&#x02009;&#x000b1;&#x02009;1.29<sup>a</sup></td></tr><tr><td align="left">&#x02003;Group 5</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">30.20&#x02009;&#x000b1;&#x02009;1.54<sup>a</sup></td><td align="char" char=".">30.21&#x02009;&#x000b1;&#x02009;1.88<sup>a</sup></td></tr><tr><td align="left">&#x02003;Group 6</td><td align="char" char=".">0/3</td><td>Nil</td><td align="char" char=".">28.20&#x02009;&#x000b1;&#x02009;1.67<sup>a</sup></td><td align="char" char=".">28.21&#x02009;&#x000b1;&#x02009;1.30<sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;4); mean values with different lowercase letters as superscripts across a row are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF20"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0017"><title>Antimalarial effects of MEFZ</title><p>As shown in <xref rid="t0003" ref-type="table">Table 3</xref>, after 72&#x02009;h post-inoculation of the mice with <italic>P. berghei</italic> (day 0), there was no significant (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) difference when the parasitaemia levels of passaged mice (groups 2&#x02013;6) were compared. However, after treatment for 4 consecutive days, the results show that percentage parasitemia decreased significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) in the MEFZ-treated groups when compared to the parasite control group. The extract also showed a dose-dependent percentage chemosuppression and percentage inhibition of <italic>P. berghei</italic>. At 600&#x02009;mg/kg b.w., MEFZ produced 95.95% and 92.67% chemosuppression and percentage inhibition of <italic>P. berghei</italic>, respectively, comparable to 98.67% and 97.29% by combisunate, a standard antimalarial. The IC<sub>50</sub> of MEFZ was estimated to be 235.23&#x02009;mg/kg b.w. Hence, the antimalarial effect of the extract at 600&#x02009;mg/kg b.w. is comparable with that by standard antimalarial drug (combisunate at 140&#x02009;mg/kg b.w.).</p><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Percentage malaria parasitaemia, chemosuppression, and percentage inhibition in <italic>P. berghei</italic> passaged mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Groups</th><th align="center">Day 0&#x02009;MP (%)</th><th align="center">Day 3&#x02009;MP (%)</th><th align="center">Day 3 chemosuppression (%)</th><th align="center">Day 3 percentage inhibition</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">0.00&#x02009;&#x000b1;&#x02009;0.00<sup>aA</sup></td><td align="char" char=".">0.00&#x02009;&#x000b1;&#x02009;0.00<sup>aA</sup></td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">Group 2</td><td align="char" char=".">45.75&#x02009;&#x000b1;&#x02009;8.18<sup>bA</sup></td><td align="char" char=".">86.50&#x02009;&#x000b1;&#x02009;5.0<sup>eB</sup></td><td align="center">&#x02013;</td><td align="center">&#x02013;</td></tr><tr><td align="left">Group 3</td><td align="char" char=".">42.50&#x02009;&#x000b1;&#x02009;6.45<sup>bB</sup></td><td align="char" char=".">1.15&#x02009;&#x000b1;&#x02009;0.15<sup>dA</sup></td><td align="char" char=".">98.67&#x02009;&#x000b1;&#x02009;9.72<sup>a</sup></td><td align="char" char=".">97.29&#x02009;&#x000b1;&#x02009;9.77<sup>a</sup></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">48.25&#x02009;&#x000b1;&#x02009;6.34<sup>bB</sup></td><td align="char" char=".">15.25&#x02009;&#x000b1;&#x02009;2.50<sup>cA</sup></td><td align="char" char=".">82.37&#x02009;&#x000b1;&#x02009;5.05<sup>c</sup></td><td align="char" char=".">68.39&#x02009;&#x000b1;&#x02009;6.07<sup>d</sup></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">49.50&#x02009;&#x000b1;&#x02009;4.20<sup>bB</sup></td><td align="char" char=".">8.00&#x02009;&#x000b1;&#x02009;2.16<sup>bcA</sup></td><td align="char" char=".">90.75&#x02009;&#x000b1;&#x02009;5.68<sup>b</sup></td><td align="char" char=".">84.84&#x02009;&#x000b1;&#x02009;4.86<sup>c</sup></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">47.75&#x02009;&#x000b1;&#x02009;3.86<sup>bB</sup></td><td align="char" char=".">3.50&#x02009;&#x000b1;&#x02009;1.00<sup>bA</sup></td><td align="char" char=".">95.95&#x02009;&#x000b1;&#x02009;8.05<sup>a</sup></td><td align="char" char=".">92.67&#x02009;&#x000b1;&#x02009;7.41<sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); Mean values with different lowercase letters within a column and mean values with uppercase letters as superscripts across a row are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF4"><p>Group 1&#x02009;=&#x02009;Normal control (normal saline).</p></fn><fn id="TF5"><p>Group 2&#x02009;=&#x02009;Parasite control (malaria-passaged untreated).</p></fn><fn id="TF6"><p>Group 3&#x02009;=&#x02009;Standard control (malaria-passaged and treated with 140&#x02009;mg/kg b.w of combisunate).</p></fn><fn id="TF7"><p>Group 4&#x02009;=&#x02009;Malaria-passaged and treated with 200&#x02009;mg/kg b.w. of the extract.</p></fn><fn id="TF8"><p>Group 5&#x02009;=&#x02009;Malaria-passaged and treated with 400&#x02009;mg/kg b.w. of the extract.</p></fn><fn id="TF9"><p>Group 6&#x02009;=&#x02009;Malaria-passaged and treated with 600&#x02009;mg/kg b.w. of the extract.</p></fn><fn id="TF90"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0018"><title>Effect of MEFZ on the haematological indices of <italic>P. berghei</italic>-parasitized mice</title><p>The results of the effects of MEFZ on the haematological indices of <italic>Plasmodium</italic> infected mice are presented in <xref rid="t0004" ref-type="table">Table 4</xref>. Infection with malaria parasite induced significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) decreases in packed cell volume (PCV), haemoglobin (Hb) concentration, and red blood cell (RBC), white blood cell (WBC) and platelet counts of the parasitized and untreated mice when compared with normal control. However, treatment of parasitized mice with MEFZ restored the altered haematological indices comparable to that of normal control.</p><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4.</label><caption><p>Effect of the MEFZ haematological indices in <italic>P. berghei</italic>-infected mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Groups</th><th colspan="5" align="center">Haematological indices<hr/></th></tr><tr><th align="center">PCV (%)</th><th align="center">Hb (g/dl)</th><th align="center">RBC (&#x000d7;10<sup>6</sup>)</th><th align="center">WBC (&#x000d7;10&#x02009;mm<sup>3</sup>)</th><th align="center">Platelet (&#x000d7;10&#x02009;mm<sup>9</sup>)</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">41.50&#x02009;&#x000b1;&#x02009;1.29<sup>d</sup></td><td align="char" char=".">12.85&#x02009;&#x000b1;&#x02009;0.25<sup>c</sup></td><td align="char" char=".">10.73&#x02009;&#x000b1;&#x02009;0.23<sup>c</sup></td><td align="char" char=".">10,825.00&#x02009;&#x000b1;&#x02009;655.11<sup>b</sup></td><td align="char" char=".">16,225.00&#x02009;&#x000b1;&#x02009;250.00<sup>b</sup></td></tr><tr><td align="left">Group 2</td><td align="char" char=".">27.00&#x02009;&#x000b1;&#x02009;2.58<sup>a</sup></td><td align="char" char=".">7.10&#x02009;&#x000b1;&#x02009;0.26<sup>a</sup></td><td align="char" char=".">5.54&#x02009;&#x000b1;&#x02009;0.90<sup>a</sup></td><td align="char" char=".">9325.00&#x02009;&#x000b1;&#x02009;377.49<sup>a</sup></td><td align="char" char=".">13,625.00&#x02009;&#x000b1;&#x02009;1833.71<sup>a</sup></td></tr><tr><td align="left">Group 3</td><td align="char" char=".">33.00&#x02009;&#x000b1;&#x02009;2.58<sup>b</sup></td><td align="char" char=".">11.55&#x02009;&#x000b1;&#x02009;0.30<sup>b</sup></td><td align="char" char=".">9.56&#x02009;&#x000b1;&#x02009;0.35<sup>b</sup></td><td align="char" char=".">11,400.00&#x02009;&#x000b1;&#x02009;565.69<sup>c</sup></td><td align="char" char=".">16,475.00&#x02009;&#x000b1;&#x02009;309.57<sup>b</sup></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">38.00&#x02009;&#x000b1;&#x02009;1.63<sup>c</sup></td><td align="char" char=".">12.18&#x02009;&#x000b1;&#x02009;0.49<sup>bc</sup></td><td align="char" char=".">10.56&#x02009;&#x000b1;&#x02009;0.63<sup>c</sup></td><td align="char" char=".">11,200.00&#x02009;&#x000b1;&#x02009;408.25<sup>bc</sup></td><td align="char" char=".">16,325.00&#x02009;&#x000b1;&#x02009;590.90<sup>b</sup></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">39.25&#x02009;&#x000b1;&#x02009;2.22<sup>cd</sup></td><td align="char" char=".">12.10&#x02009;&#x000b1;&#x02009;0.29<sup>bc</sup></td><td align="char" char=".">10.77&#x02009;&#x000b1;&#x02009;0.16<sup>c</sup></td><td align="char" char=".">10,475.00&#x02009;&#x000b1;&#x02009;298.61<sup>b</sup></td><td align="char" char=".">16,125.00&#x02009;&#x000b1;&#x02009;727.44<sup>b</sup></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">40.50&#x02009;&#x000b1;&#x02009;1.00<sup>cd</sup></td><td align="char" char=".">12.25&#x02009;&#x000b1;&#x02009;0.65<sup>c</sup></td><td align="char" char=".">10.45&#x02009;&#x000b1;&#x02009;0.20<sup>c</sup></td><td align="char" char=".">10,775.00&#x02009;&#x000b1;&#x02009;512.35<sup>b</sup></td><td align="char" char=".">15,600.00&#x02009;&#x000b1;&#x02009;1116.54<sup>b</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF10"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); Mean values with different letters as superscripts in a column are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF100"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0019"><title>Effect of the MEFZ on the liver status in <italic>P. berghei</italic>-parasitized mice</title><p>As shown in <xref rid="t0005" ref-type="table">Table 5</xref>, the activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and alkaline phosphatase (ALP) as well as total bilirubin concentration were found to be significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) higher in parasitized-untreated mice when compared to normal control. Parasitized mice treated with 200, 400, and 600&#x02009;mg/kg b.w. of MEFZ as well as the standard drug have significantly (<italic>p&#x02009;&#x0003c;</italic>&#x02009;0.05) lower serum AST, ALT, and ALP activities, and total bilirubin concentration when compared with group 2 (parasitized and untreated mice. There was no significant (<italic>p&#x02009;&#x0003e;</italic>&#x02009;0.05) difference when the liver status of the parasitized-MEFZ-treated mice was compared with that of the normal mice (group 1). This implies that the extract normalized the liver damage generated by malaria infection.</p><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5.</label><caption><p>Effect of the MEFZ on the liver status in <italic>P. berghei</italic>-infected mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Groups</th><th align="center">ALT (IU/L)</th><th align="center">AST (IU/L)</th><th align="center">ALP (IU/L)</th><th align="center">Total bilirubin (mg/dl)</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">74.00&#x02009;&#x000b1;&#x02009;4.32<bold><sup>a</sup></bold></td><td align="char" char=".">62.25&#x02009;&#x000b1;&#x02009;2.63<bold><sup>a</sup></bold></td><td align="char" char=".">91.50&#x02009;&#x000b1;&#x02009;2.65<bold><sup>b</sup></bold></td><td align="char" char=".">5.53&#x02009;&#x000b1;&#x02009;0.42<bold><sup>a</sup></bold></td></tr><tr><td align="left">Group 2</td><td align="char" char=".">107.75&#x02009;&#x000b1;&#x02009;4.19<bold><sup>d</sup></bold></td><td align="char" char=".">96.25&#x02009;&#x000b1;&#x02009;6.34<bold><sup>c</sup></bold></td><td align="char" char=".">112.50&#x02009;&#x000b1;&#x02009;5.07<bold><sup>c</sup></bold></td><td align="char" char=".">7.08&#x02009;&#x000b1;&#x02009;0.79<bold><sup>b</sup></bold></td></tr><tr><td align="left">Group 3</td><td align="char" char=".">90.25&#x02009;&#x000b1;&#x02009;2.63<bold><sup>c</sup></bold></td><td align="char" char=".">88.25&#x02009;&#x000b1;&#x02009;3.30<bold><sup>b</sup></bold></td><td align="char" char=".">97.50&#x02009;&#x000b1;&#x02009;3.87<bold><sup>b</sup></bold></td><td align="char" char=".">5.14&#x02009;&#x000b1;&#x02009;0.59<bold><sup>a</sup></bold></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">83.00&#x02009;&#x000b1;&#x02009;3.83<bold><sup>b</sup></bold></td><td align="char" char=".">67.75&#x02009;&#x000b1;&#x02009;3.10<bold><sup>a</sup></bold></td><td align="char" char=".">91.00&#x02009;&#x000b1;&#x02009;5.77<bold><sup>b</sup></bold></td><td align="char" char=".">5.64&#x02009;&#x000b1;&#x02009;0.28<bold><sup>a</sup></bold></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">76.00&#x02009;&#x000b1;&#x02009;3.37<bold><sup>a</sup></bold></td><td align="char" char=".">68.50&#x02009;&#x000b1;&#x02009;6.25<bold><sup>a</sup></bold></td><td align="char" char=".">92.25&#x02009;&#x000b1;&#x02009;4.35<bold><sup>b</sup></bold></td><td align="char" char=".">4.88&#x02009;&#x000b1;&#x02009;0.57<bold><sup>a</sup></bold></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">84.50&#x02009;&#x000b1;&#x02009;12.48<bold><sup>a</sup></bold></td><td align="char" char=".">64.00&#x02009;&#x000b1;&#x02009;2.16<bold><sup>a</sup></bold></td><td align="char" char=".">84.50&#x02009;&#x000b1;&#x02009;3.42<bold><sup>a</sup></bold></td><td align="char" char=".">5.29&#x02009;&#x000b1;&#x02009;0.72<bold><sup>a</sup></bold></td></tr></tbody></table><table-wrap-foot><fn id="TF11"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); Mean values with different letters as superscripts in a column are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF110"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0020"><title>Effect of MEFZ on the antioxidant and lipid peroxidation status of <italic>P. berghei</italic>-parasitized mice</title><p><xref rid="t0006" ref-type="table">Table 6</xref> reveals that the activities of SOD and catalase, as well as GSH concentration reduced significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) in the parasite control group when compared to parasitized-treated groups, while the MDA concentration exhibited significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increase in group 2 when compared to treated mice. However, treatment of parasitized mice with MEFZ normalized the antioxidant and lipid peroxidation status of the mice.</p><table-wrap id="t0006" orientation="portrait" position="float"><label>Table 6.</label><caption><p>Effect of MEFZ on antioxidant status of malaria passaged albino mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th rowspan="2" align="left">Groups</th><th colspan="4" align="center">Lipid peroxidation and antioxidant status<hr/></th></tr><tr><th align="center">MDA conc. (mg/dL)</th><th align="center">SOD activity (IU/L)</th><th align="center">Catalase activity (IU/L)</th><th align="center">GSH conc. (mg/dL)</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">8.493&#x02009;&#x000b1;&#x02009;0.200<sup>a</sup></td><td align="char" char=".">3.422&#x02009;&#x000b1;&#x02009;0.470<sup>b</sup></td><td align="char" char=".">1.679&#x02009;&#x000b1;&#x02009;0.195<sup>b</sup></td><td align="char" char=".">5.220&#x02009;&#x000b1;&#x02009;0.635<sup>a</sup></td></tr><tr><td align="left">Group 2</td><td align="char" char=".">14.859&#x02009;&#x000b1;&#x02009;0.748<sup>b</sup></td><td align="char" char=".">2.784&#x02009;&#x000b1;&#x02009;0.333<sup>a</sup></td><td align="char" char=".">1.131&#x02009;&#x000b1;&#x02009;0.040<sup>a</sup></td><td align="char" char=".">4.858&#x02009;&#x000b1;&#x02009;0.525<sup>a</sup></td></tr><tr><td align="left">Group 3</td><td align="char" char=".">8.308&#x02009;&#x000b1;&#x02009;1.885<sup>a</sup></td><td align="char" char=".">4.801&#x02009;&#x000b1;&#x02009;0.415<sup>c</sup></td><td align="char" char=".">1.654&#x02009;&#x000b1;&#x02009;0.236<sup>b</sup></td><td align="char" char=".">5.281&#x02009;&#x000b1;&#x02009;0.422<sup>a</sup></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">7.597&#x02009;&#x000b1;&#x02009;1.089<sup>a</sup></td><td align="char" char=".">3.620&#x02009;&#x000b1;&#x02009;0.378<sup>b</sup></td><td align="char" char=".">1.578&#x02009;&#x000b1;&#x02009;0.267<sup>b</sup></td><td align="char" char=".">5.144&#x02009;&#x000b1;&#x02009;0.791<sup>a</sup></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">7.485&#x02009;&#x000b1;&#x02009;0.995<sup>a</sup></td><td align="char" char=".">4.597&#x02009;&#x000b1;&#x02009;0.448<sup>c</sup></td><td align="char" char=".">1.535&#x02009;&#x000b1;&#x02009;0.413<sup>b</sup></td><td align="char" char=".">5.482&#x02009;&#x000b1;&#x02009;0.210<sup>a</sup></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">7.836&#x02009;&#x000b1;&#x02009;0.561<sup>a</sup></td><td align="char" char=".">4.902&#x02009;&#x000b1;&#x02009;0.483<sup>c</sup></td><td align="char" char=".">1.585&#x02009;&#x000b1;&#x02009;0.074<sup>b</sup></td><td align="char" char=".">5.582&#x02009;&#x000b1;&#x02009;0.272<sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF12"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); mean values with different letters as superscripts in a column are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF120"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0021"><title>Effect of MEFZ on the lipid profile of <italic>P. berghei</italic>-parasitized mice</title><p>The result of the lipid profile in <xref rid="t0007" ref-type="table">Table 7</xref> shows that the mean total cholesterol levels of mice in groups 3&#x02013;6 were non-significantly (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) lower than the values for mice in group 2. There was non-significant (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) elevation in the HDL concentration of mice in all the parasitized mice treated with graded doses of MEFZ and standard drug when compared to the parasite control group. However, LDL concentration of mice in groups 3&#x02013;6 were non-significantly (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) lower than those of parasite control. Triacylglycerol (TAG) concentrations of mice in groups 3&#x02013;6 were non-significantly (<italic>p</italic>&#x02009;&#x0003e;&#x02009;0.05) lower than parasite control.</p><table-wrap id="t0007" orientation="portrait" position="float"><label>Table 7.</label><caption><p>Effect of MEFZ on lipid profile of malaria-passaged albino mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">Groups</th><th align="center">HDL (mg/dl)</th><th align="center">TAG (mg/dl)</th><th align="center">LDL (mg/dl)</th><th align="center">Total cholesterol (mg/dl)</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">61.75&#x02009;&#x000b1;&#x02009;1.71<sup>c</sup></td><td align="char" char=".">85.75&#x02009;&#x000b1;&#x02009;4.03<sup>a</sup></td><td align="char" char=".">17.25&#x02009;&#x000b1;&#x02009;2.22<sup>a</sup></td><td align="char" char=".">82.25&#x02009;&#x000b1;&#x02009;6.65<sup>a</sup></td></tr><tr><td align="left">Group 2</td><td align="char" char=".">16.25&#x02009;&#x000b1;&#x02009;4.65<sup>a</sup></td><td align="char" char=".">100.75&#x02009;&#x000b1;&#x02009;2.50<sup>abc</sup></td><td align="char" char=".">86.25&#x02009;&#x000b1;&#x02009;5.80<sup>c</sup></td><td align="char" char=".">96.00&#x02009;&#x000b1;&#x02009;2.83<sup>c</sup></td></tr><tr><td align="left">Group 3</td><td align="char" char=".">51.75&#x02009;&#x000b1;&#x02009;3.10<sup>b</sup></td><td align="char" char=".">90.50&#x02009;&#x000b1;&#x02009;3.42<sup>ab</sup></td><td align="char" char=".">24.50&#x02009;&#x000b1;&#x02009;3.42<sup>b</sup></td><td align="char" char=".">83.75&#x02009;&#x000b1;&#x02009;3.86<sup>ab</sup></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">64.00&#x02009;&#x000b1;&#x02009;3.65<sup>c</sup></td><td align="char" char=".">93.25&#x02009;&#x000b1;&#x02009;7.63<sup>a</sup></td><td align="char" char=".">16.75&#x02009;&#x000b1;&#x02009;0.96<sup>a</sup></td><td align="char" char=".">90.25&#x02009;&#x000b1;&#x02009;3.86<sup>bc</sup></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">61.75&#x02009;&#x000b1;&#x02009;3.10<sup>c</sup></td><td align="char" char=".">92.25&#x02009;&#x000b1;&#x02009;5.32<sup>bc</sup></td><td align="char" char=".">16.25&#x02009;&#x000b1;&#x02009;4.65<sup>a</sup></td><td align="char" char=".">84.00&#x02009;&#x000b1;&#x02009;5.66<sup>ab</sup></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">67.50&#x02009;&#x000b1;&#x02009;5.00<sup>c</sup></td><td align="char" char=".">92.75&#x02009;&#x000b1;&#x02009;2.50<sup>c</sup></td><td align="char" char=".">20.50&#x02009;&#x000b1;&#x02009;3.42<sup>ab</sup></td><td align="char" char=".">81.50&#x02009;&#x000b1;&#x02009;1.91<sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF13"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); Mean values with different letters as superscripts in a column are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF130"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec><sec id="s0022"><title>Effect of MEFZ on some electrolyte concentrations in malaria passaged mice</title><p>As shown in <xref rid="t0008" ref-type="table">Table 8</xref>, the concentrations of potassium and chloride ions of parasite control mice were significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) lower, while their sodium ion level was significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) higher when compared with parasitized-MEFZ-treated mice.</p><table-wrap id="t0008" orientation="portrait" position="float"><label>Table 8.</label><caption><p>Effect of MEFZ on some electrolyte concentrations in malaria-passaged mice.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="1*"/><col width="1*"/><col width="1*"/><col width="1*"/></colgroup><thead><tr><th align="left">&#x000a0;</th><th colspan="3" align="center">Electrolyte concentrations (mmol/l)<hr/></th></tr><tr><th align="left">Treatment group</th><th align="center">Potassium (K<sup>+</sup>)</th><th align="center">Sodium (Na<sup>+</sup>)</th><th align="center">Chloride (Cl<sup>-</sup>)</th></tr></thead><tbody valign="top"><tr><td align="left">Group 1</td><td align="char" char=".">5.13&#x02009;&#x000b1;&#x02009;0.22<sup>cd</sup></td><td align="char" char=".">129.50&#x02009;&#x000b1;&#x02009;3.41<sup>b</sup></td><td align="char" char=".">7.79&#x02009;&#x000b1;&#x02009;0.71<sup>a</sup></td></tr><tr><td align="left">Group 2</td><td align="char" char=".">3.20&#x02009;&#x000b1;&#x02009;0.16<sup>a</sup></td><td align="char" char=".">146.00&#x02009;&#x000b1;&#x02009;6.73<sup>a</sup></td><td align="char" char=".">6.50&#x02009;&#x000b1;&#x02009;0.50<sup>b</sup></td></tr><tr><td align="left">Group 3</td><td align="char" char=".">4.23&#x02009;&#x000b1;&#x02009;0.26<sup>b</sup></td><td align="char" char=".">129.75&#x02009;&#x000b1;&#x02009;8.26<sup>b</sup></td><td align="char" char=".">7.43&#x02009;&#x000b1;&#x02009;0.56<sup>a</sup></td></tr><tr><td align="left">Group 4</td><td align="char" char=".">4.60&#x02009;&#x000b1;&#x02009;0.50<sup>bc</sup></td><td align="char" char=".">132.75&#x02009;&#x000b1;&#x02009;2.50<sup>ab</sup></td><td align="char" char=".">7.15&#x02009;&#x000b1;&#x02009;0.31<sup>a</sup></td></tr><tr><td align="left">Group 5</td><td align="char" char=".">4.35&#x02009;&#x000b1;&#x02009;0.20<sup>cd</sup></td><td align="char" char=".">132.67&#x02009;&#x000b1;&#x02009;3.06<sup>b</sup></td><td align="char" char=".">7.80&#x02009;&#x000b1;&#x02009;0.87<sup>b</sup></td></tr><tr><td align="left">Group 6</td><td align="char" char=".">4.64&#x02009;&#x000b1;&#x02009;0.29<sup>d</sup></td><td align="char" char=".">128.40&#x02009;&#x000b1;&#x02009;3.65<sup>b</sup></td><td align="char" char=".">7.92&#x02009;&#x000b1;&#x02009;0.41<sup>a</sup></td></tr></tbody></table><table-wrap-foot><fn id="TF14"><p>Results are expressed in means&#x02009;&#x000b1;&#x02009;SD (<italic>n</italic>&#x02009;=&#x02009;5); mean values with different letters as superscripts in a column are considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></fn><fn id="TF140"><p><italic>Note:</italic> The alphabets in superscript are statistical codes signifying the statistical relationships between two variables. Same alphabet as superscript means that there was no statistical difference between the body weights before and after extract administration.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s0023"><title>Discussion</title><p>Malaria remains an overwhelming infectious disease with significant health challenges in African and other endemic countries globally (Lawal et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2015</xref>). In the present study, MEFZ showed a dose-dependent reduction in percentage malaria parasitaemia and, hence, an increase in parasite clearance. This result agrees with the views of Medhi et&#x000a0;al. (<xref rid="CIT0056" ref-type="bibr">2013</xref>) who classified <italic>F. zanthoxyloides</italic> as a medicinal plant with antimalarial properties. The presence of phytochemicals such flavonoids, terpenoids, phenols, alkaloids, glycosides, tannins, steroids, and saponins in the extract which have earlier been shown to have antiplasmodial effects (Saxena et&#x000a0;al. <xref rid="CIT0081" ref-type="bibr">2003</xref>; Khaomek et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2008</xref>), could be responsible for the antimalarial effect observed in this study. Specifically, the presence of alkaloids in this plant is in accordance with the report of Elujoba et&#x000a0;al. (<xref rid="CIT0025" ref-type="bibr">2005</xref>), who described the main active ingredients in <italic>F. zanthoxyloides</italic> as alkaloids: berberine, fagaronine, chelerythrine, canthin-6-one, and benzoic acid derivatives. Kassim et&#x000a0;al. (<xref rid="CIT0041" ref-type="bibr">2005</xref>) showed that fagaronine also inhibited <italic>P. falciparum</italic> growth <italic>in vitro</italic> with an IC<sub>50</sub> value of 0.018&#x02009;&#x003bc;g/mL. Fagaronine has also been shown to inhibit the growth and cell differentiation of human erythroleukaemia K562 cells and L1210 murine leukaemia cells (Prado et&#x000a0;al. <xref rid="CIT0075" ref-type="bibr">2004</xref>). The presence of tannins, saponins, and flavonoids agrees with the report of Adefisoye et&#x000a0;al. (<xref rid="CIT0002" ref-type="bibr">2012</xref>). These compounds are known to be biologically active and have been shown to possess antimicrobial (Okeke et&#x000a0;al., <xref rid="CIT0066" ref-type="bibr">2001</xref>) and antimalarial effects. Takanishi et&#x000a0;al. (<xref rid="CIT0089" ref-type="bibr">1999</xref>) reported that fagaronine, at a dose of 75&#x02009;mg/kg b.w. showed cytotoxic activity against transplantable murine tumour P-388 cells. Berberine-rich plants have been shown to exhibit antimalarial activity (Caraballo et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2004</xref>; Chandel et&#x000a0;al. <xref rid="CIT0017" ref-type="bibr">2015</xref>). Similarly, berberine and its analogs have been shown to exhibit antimalarial activity and as well, protect organs of malaria infected mice (Silikas et&#x000a0;al. <xref rid="CIT0082" ref-type="bibr">1996</xref>; Iwasa et&#x000a0;al. <xref rid="CIT0039" ref-type="bibr">1998</xref>; Dkhil et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015a</xref>, <xref rid="CIT0021" ref-type="bibr">2015b</xref>). The mechanism of antimalarial activity of the extract may be attributed to the presence of berberine and fagaronine earlier reported in the extract (Elujoba et&#x000a0;al. <xref rid="CIT0025" ref-type="bibr">2005</xref>). Berberine has been shown to inhibit plasmodial telomerase activity (Sriwilaijareon et&#x000a0;al. <xref rid="CIT0085" ref-type="bibr">2002</xref>; Parida et&#x000a0;al. <xref rid="CIT0072" ref-type="bibr">2014</xref>) while fagaronine is demonstrated to inhibit plasmodial DNA topoisomerases I and II. Fagaronine also acts as a DNA intercalating agent (Larsen et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">1993</xref>).</p><p>Haematological indices such as platelet counts, total white blood cell (WBC) count, red blood cell (RBC) count, packed cell volume (PCV) and haemoglobin (Hb) level are common biomarkers of malarial infection and frequently monitored as indicators of drug efficacy against plasmodial infection. Haemoglobin has the physiological function of transporting oxygen to tissues of the animal for the oxidation of ingested food so as to release energy for the other body functions as well as transport carbon dioxide out of the body (Ugwuene <xref rid="CIT0094" ref-type="bibr">2011</xref>; Isaac et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2013</xref>). Similarly, PCV is an indicator of the body&#x02019;s ability to transport oxygen and absorbed nutrients. An increased PCV shows a better transportation capacity of the red blood cells (Isaac et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2013</xref>). Packed cell volume is used to assess anaemia, erythrocytosis, haemodilution, and haemoconcentration (Ugwu et&#x000a0;al. <xref rid="CIT0093" ref-type="bibr">2013</xref>). A decrease in PCV indicates anaemia (Ugwu et&#x000a0;al. <xref rid="CIT0093" ref-type="bibr">2013</xref>; Briggs and Bain <xref rid="CIT0014" ref-type="bibr">2017</xref>). Changes in RBC count are the most typical features of malarial infections and anaemia is the most common complication associated with malaria infection (Erhart et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2004</xref>). The ability of the MEFZ to restore Hb level, PCV and RBC count in parasitized-MEFZ-treated mice (groups 4, 5, and 6) when compared with parasitized-untreated mice suggests that the extract possess erythropoietic activity. In the same vein, the ability of MEFZ to normalize the reduction in WBC in the parasitized-MEFZ-treated mice when compared with parasitized-untreated showed that the extract has immunostimulatory effects. This may explain why there was a reduction percentage in malaria parasitaemia in parasitized-MEFZ-treated mice. In addition, MEFZ significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increased the platelet count of parasitized-MEFZ-treated mice when compared to parasitized-untreated. This result agrees with the opinion of Ifeanyichukwu and Esan (<xref rid="CIT0035" ref-type="bibr">2014</xref>) that thrombocytopenia (low platelet count) usually disappears with the treatment of malaria infection. Malaria has been reported as the major cause of thrombocytopenia in malaria endemic areas (Ifeanyichukwu and Esan <xref rid="CIT0035" ref-type="bibr">2014</xref>). Platelets engulf malaria parasites and get damaged in the process and thus are removed from circulation, leading to a reduction in platelet count during malaria (Ifeanyichukwu and Esan <xref rid="CIT0035" ref-type="bibr">2014</xref>). The haematopoietic effects observed in this study could be attributed to the phytoconstituents such as alkaloids, tannins, glycosides, and terpenoids. These phytoconstituents have been shown to increase the release of erythropoietin, the hormone that boosts RBC production as well as stimulates stem cells to divide into blood cells. Koffuor et&#x000a0;al. (<xref rid="CIT0046" ref-type="bibr">2012</xref>) demonstrated that plants rich in alkaloids, tannins, glycosides, and terpenoids exhibited haematopoietic effect in rabbits.</p><p>In parasitized mice, liver enzyme activities in the serum increase due to disruption of the liver membrane by malaria parasite during exo-erythrocytic stage as well as the products of their damage to RBCs during erythrocytic stage which affect the liver. However, treatment with MEFZ significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) reduced the activities of liver marker enzymes (AST, ALP, and ALT) in the serum of parasitized-MEFZ-treated mice when compared with the parasitized-untreated. This is in line with the previous report that leaf extract of <italic>F. zanthoxyloides</italic>, at high concentrations normalizes these enzymes activities in the serum (Enechi and Ugwu <xref rid="CIT0026" ref-type="bibr">2013</xref>). The normalization of liver function enzymes observed may be linked with the membrane stabilization and maintenance of hepatocyte integrity potentials (Oyedapo and Famurewa <xref rid="CIT0071" ref-type="bibr">1995</xref>), by preventing the leakage of liver enzymes into circulation. Reduction in RBC destruction by malaria parasite due to the antiplasmodial effect of MEFZ might be responsible for the reduction in serum levels of total serum bilirubin in the parasitized-MEFZ-treated mice when compared to parasitized-untreated mice (Trampuz et&#x000a0;al. <xref rid="CIT0090" ref-type="bibr">2003</xref>).</p><p>In malaria infection, free radicals are generated from various sources such as host immune response, parasite metabolic activity, and haemoglobin degradation. When the level of free radicals overwhelms the body&#x02019;s antioxidant defence, oxidative stress &#x02013; a condition implicated in malaria complications results (Sandro et&#x000a0;al. <xref rid="CIT0080" ref-type="bibr">2012</xref>). The antiplasmodial and antioxidant activities of many plants have been linked to the presence of alkaloids, terpenoids, flavonoids and some other phenolic compounds in them (Momoh and Longe <xref rid="CIT0058" ref-type="bibr">2014</xref>). The significant reduction in the MDA level of parasitized-MEFZ-treated mice when compared to parasitized-untreated mice shows that the extract reduced the level of lipid peroxidation. George et&#x000a0;al. (<xref rid="CIT0030" ref-type="bibr">2012</xref>) reported that aqueous extract of <italic>Aframomum sceptrum</italic> (Oliv. &#x00026; Hanb.) K Schum (Zingiberaceae) reduced the MDA level of parasitized mice. MDA is a major oxidation product that indicates the status of lipid peroxidation which is implicated in many pathologic conditions (Noori <xref rid="CIT0059" ref-type="bibr">2012</xref>). Also, treatment of parasitized mice with MEFZ significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increased the activity of antioxidant enzymes (SOD and CAT) and concentration of GSH when compared with parasitized-untreated mice. This is also in line with the report by George et&#x000a0;al. (<xref rid="CIT0030" ref-type="bibr">2012</xref>) that aqueous extract of <italic>A. sceptrum</italic> increased antioxidant status of malaria-passaged mice. This dose-dependent increase in both enzymatic and non-enzymatic antioxidant potentials could be attributed to phytoconstituents such as flavonoids and phenols detected in high concentrations in MEFZ. Chaaib et&#x000a0;al. (<xref rid="CIT0016" ref-type="bibr">2003</xref>) have shown that the root of the plant possesses antioxidant effects. Generally, the biological system protects itself against the damaging effect of reactive species by the action of free radical scavengers and chain terminating enzymes such as SOD, CAT, and GSH (Rahman et&#x000a0;al. <xref rid="CIT0077" ref-type="bibr">2012</xref>).</p><p>Infection of mice with malaria parasite decreased the HDL level when compared with normal control. Kiru et&#x000a0;al. (<xref rid="CIT0045" ref-type="bibr">2018</xref>) reported that malaria infected human subjects had higher LDL, TAG, HDL, VLDL, and total cholesterol levels when compared with control. Meanwhile, treatment of parasitized mice with MEFZ significantly (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increased the HDL concentration when compared with parasitized-untreated mice. On the other hand, treatment of parasitized mice with MEFZ reduced the TAG, LDL, and total cholesterol concentrations in the parasitized and treated mice when compared with parasitized-untreated mice. In children with malaria by <italic>P. vivax</italic>, Dias et&#x000a0;al. (<xref rid="CIT0019" ref-type="bibr">2016</xref>) reported significantly lower levels of total cholesterol, LDL, and HDL, and significantly higher levels of VLDL and TAG. Dungdung et&#x000a0;al. (<xref rid="CIT0023" ref-type="bibr">2018</xref>) reported that the total cholesterol, HDL and LDL were significantly decreased while TAG and VLDL were not significantly changed in <italic>P. falciparum</italic> malaria patients. Changes in serum lipid profile and lipid metabolism are due to a whole range of partially disease-specific mechanisms (Khovidhunkit et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2004</xref>). The extent of serum lipid profile changes during malaria infection and their underlying biological mechanisms remain unclear. A meta-analysis by Visser et&#x000a0;al. (<xref rid="CIT0096" ref-type="bibr">2013</xref>) showed that changes in serum lipids are a characteristic feature of malaria. Patients with malaria present hypocholesterolemia, decreased HDL level, and elevation in the LDL level, which are accompanied by increased levels of TAGs and very low-density lipoproteins (VLDL). Such lipid abnormalities are transient, occurring in the most prevalent species of <italic>Plasmodium</italic> as well as in complicated or non-complicated cases. This is because lipids play a crucial role in the metabolism of <italic>Plasmodium,</italic> in both phases of its life cycle (Visser et&#x000a0;al. <xref rid="CIT0096" ref-type="bibr">2013</xref>). The actual mechanisms behind the observed dyslipidaemia in malaria may be partly host related (i.e., related to an acute phase response to parasite invasion (Rosenson et&#x000a0;al. <xref rid="CIT0079" ref-type="bibr">2007</xref>), parasite-related (Holz <xref rid="CIT0033" ref-type="bibr">1977</xref>; Hanscheid et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2007</xref>) or a combination of these two. However, it was observed that malaria infection induced dyslipidaemia which was normalized in this study by treatment of parasitized mice with MEFZ.</p><p>To evaluate the effect of the extract on the kidney dysfunction generated by malaria infection, serum electrolyte concentrations of parasitized-MEFZ-extract-treated mice and parasitized-untreated mice were assessed and compared. On the one hand, the result revealed a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) decrease in the potassium and chloride levels, and a significant (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05) increase in sodium level of the parasitized-untreated mice when compared with normal control. Result of the present study agrees with the report of Baloch et&#x000a0;al. (<xref rid="CIT0009" ref-type="bibr">2011</xref>) that found decreased chloride level but increased sodium and potassium levels in malaria-infected human individuals when compared with control. Similarly, Ikekpeazu et&#x000a0;al. (<xref rid="CIT0036" ref-type="bibr">2010</xref>) and Kiru et&#x000a0;al. (<xref rid="CIT0045" ref-type="bibr">2018</xref>) reported decreased sodium and potassium levels but no significant difference in chloride level when malaria infected human subjects were compared with control. On the other hand, Ogbadoyi and Gabi (<xref rid="CIT0062" ref-type="bibr">2015</xref>) and Ani (2015) found no significant difference when the sodium, chloride and potassium levels of malaria infected human subjects were compared with the controls. It appears that alteration in serum electrolyte indices in malaria infection is dependent on the species of the malaria parasite (Jasani et&#x000a0;al. <xref rid="CIT0040" ref-type="bibr">2012</xref>), parasite density (van Wolfswinkel et&#x000a0;al. <xref rid="CIT0095" ref-type="bibr">2010</xref>), and immunological status as well as other genetic make-up of the host. In general, malaria infection alters serum electrolyte balance, suggesting that malaria infection induces renal dysfunction. Treatment of parasitized mice with MEFZ restored the electrolyte levels to normal. Electrolytes are particles or solutes found throughout the body in fluids and are important kidney markers. They carry electrical charges and regulate acid&#x02013;base balance, fluid balance, and osmolarity, and promote neuromuscular functions or fluidity. They also distribute the body&#x02019;s fluid and water between the compartments (Stooper <xref rid="CIT0086" ref-type="bibr">2015</xref>).</p><p>The result of an acute toxicity test of MEFZ showed that the extract was not lethal even at the highest dosage (5000&#x02009;mg/kg body weight) administered. There was no morphological, behavioural or significant body weight change observed within 24&#x02009;h of acute toxicity study. The result of this study suggests that the lethal dose of the extract is above 5000&#x02009;mg/kg body weight. This result contradicts the report of Ogwal-Okeng et&#x000a0;al. (<xref rid="CIT0064" ref-type="bibr">2003</xref>) who showed that methanol extract of <italic>F. zanthoxyloides</italic> root-bark is lethal at doses above 2000&#x02009;mg/kg body weight. The variation between these findings could be attributed to the differences in the part of the plant used as well as the soil in which the plant is grown. Ogwal-Okeng et&#x000a0;al. (<xref rid="CIT0064" ref-type="bibr">2003</xref>) used root-bark while the present study used leaves. Roots of plants are usually more toxic than other parts of the plants because of higher bioaccumulation of toxicants from the soil. The toxicity becomes severe when the plant is grown in contaminated soil such as heavy metal contaminated and oil polluted soil. In any case, the present study showed that MEFZ has a high safety profile.</p></sec><sec id="s0024"><title>Conclusions</title><p>This study demonstrated that the methanol extract of <italic>F. zanthoxyloides</italic> leaves has antimalarial potentials. It, hence, justifies the ethno-medicinal use of <italic>F. zanthoxyloides</italic> in the management of malaria. This effect might be attributed to the presence of pharmacologically active principles in the extract which may have acted singly or in synergy with one another to exert the antimalarial activity observed in this study. The study also showed that the extract could also offer protection against oxidative stress and lipid peroxidation associated with malaria infection. The plant extract also significantly restored altered haematological and biochemical indices induced by malaria. The isolation and the characterization of the antimalarial principles in this extract are warranted. The active ingredients also should be subjected to clinical trials as they might facilitate the development of a new generation of effective antimalarial agents.</p></sec></body><back><sec id="s0025"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the authors.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abu</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Anyaibe</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Headings</surname><given-names>V</given-names></name></person-group>
<year>1981</year>
<article-title>Chromatographic fractionation of anti-sickling agents in <italic>Fagara zanthoxyloides</italic></article-title>. <source>Acta Haematol</source>. <volume>66</volume>(<issue>1</issue>):<fpage>19</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">6794294</pub-id></mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adefisoye</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Ako-Nai</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Bisi-Johnson</surname><given-names>MA</given-names></name></person-group>
<year>2012</year>
<article-title>Phytochemical and antibacterial activity of the extracts of <italic>Fagara zanthoxyloides</italic> on selected carcinogenic and enteric bacterial isolates</article-title>. <source>J Intercult Ethnopharmacol</source>. <volume>1</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>6</lpage>.</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Adesina</surname><given-names>SK</given-names></name></person-group>
<year>2005</year>
<article-title>The Nigerian <italic>Zanthoxylum</italic>; Chemical and biological values</article-title>. <source>Afr J Tradit Complement Altern Med</source>. <volume>2</volume>:<fpage>282</fpage>&#x02013;<lpage>301</lpage>.</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Aebi</surname><given-names>HE</given-names></name></person-group>
<year>1983</year>
<chapter-title>Catalase</chapter-title> In: <person-group person-group-type="editor"><name name-style="western"><surname>Bergmeyer</surname><given-names>HU</given-names></name></person-group>, editor. <source>Methods of enzymatic analysis</source>. <publisher-loc>Weinhem (Germany)</publisher-loc>: <publisher-name>Verlag Chemie</publisher-name>; p. <fpage>273</fpage>&#x02013;<lpage>286</lpage>.</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alkadi</surname><given-names>HO</given-names></name></person-group>
<year>2007</year>
<article-title>Antimalarial drug toxicity: a review</article-title>. <source>Chemotherapy</source>. <volume>53</volume>(<issue>6</issue>):<fpage>385</fpage>&#x02013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">17934257</pub-id></mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aloke</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nwachukwu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ugwuja</surname><given-names>EI</given-names></name>, <name name-style="western"><surname>Idenyi</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Nwachi</surname><given-names>EU</given-names></name>, <name name-style="western"><surname>Obasi</surname><given-names>IO</given-names></name>, <name name-style="western"><surname>Oga</surname><given-names>O</given-names></name></person-group>
<year>2012</year>
<article-title>Effects of <italic>Zanthoxylum zanthoxyloides</italic> leaves on blood glucose, lipid profile and some liver enzymes in alloxan induced diabetic rats</article-title>. <source>Int J Sci Nat</source>. <volume>3</volume>:<fpage>497</fpage>&#x02013;<lpage>501</lpage>.</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="thesis"><person-group person-group-type="author"><name name-style="western"><surname>Ani</surname><given-names>OC</given-names></name></person-group>
<year>2015</year>. Assessment of the role of malaria in the aetiology of renal impairment in Isu community in Ebonyi State, Nigeria [PhD thesis]. Department of Zoology and Environmental Biology, University of Nigeria, Nsukka.</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Bain</surname><given-names>BJ</given-names></name></person-group>
<year>2017</year>
<chapter-title>Preparation and staining methods for blood and bone marrow films</chapter-title> In: <source>Dacie and Lewis practical haematology</source>. <edition>12th ed</edition>
<publisher-loc>New York (NY)</publisher-loc>: <publisher-name>Elsevier</publisher-name>; p. <fpage>1</fpage>&#x02013;<lpage>11</lpage>.</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baloch</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gachal</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Memon</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Baloch</surname><given-names>M</given-names></name></person-group>
<year>2011</year>
<article-title>Electrolyte concentration in malarial patients by flame photometer</article-title>. <source>J Bacteriol Parasitol</source>. <volume>02</volume>(<issue>06</issue>):<fpage>123</fpage>&#x02013;<lpage>125</lpage>.</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Balogun</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Akinloye</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Lasisi</surname><given-names>A</given-names></name></person-group>
<year>2012</year>
<article-title>Biochemical and histological changes associated with diabetes mellitus in mice with extracts of <italic>Mormodiaca charantia</italic></article-title>. <source>Biochemistry</source>. <volume>24</volume>:<fpage>34</fpage>&#x02013;<lpage>47</lpage>.</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnabas</surname><given-names>BB</given-names></name>, <name name-style="western"><surname>Mann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ogunrinola</surname><given-names>TS</given-names></name>, <name name-style="western"><surname>Anyanwu</surname><given-names>PE</given-names></name></person-group>
<year>2011</year>
<article-title>Screening for anthelminthic activities from extracts of <italic>Zanthoxylum zanthoxyloides</italic>, <italic>Neocarya macrophylla</italic> and <italic>Celosia laxa</italic> against <italic>Ascaris</italic> infection in rabbits</article-title>. <source>Int J Appl Res Nat Prod</source>. <volume>3</volume>(<issue>4</issue>):<fpage>1</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bitta</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Kariuki</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Mwita</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Gwer</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mwai</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Newton</surname><given-names>C</given-names></name></person-group>
<year>2017</year>
<article-title>Antimalarial drugs and the prevalence of mental and neurological manifestations: a systematic review and meta-analysis</article-title>. <source>Wellcome Open Res</source>. <volume>2</volume>:<fpage>13</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">28630942</pub-id></mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boareto</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>M&#x000fc;ller</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>de Araujo</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Louren&#x000e7;o</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Louren&#x000e7;o</surname><given-names>ELB</given-names></name>, <name name-style="western"><surname>Gomes</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Minatovicz</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lombardi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Paumgartten</surname><given-names>FR</given-names></name>, <name name-style="western"><surname>Dalsenter</surname><given-names>PR</given-names></name></person-group>
<year>2012</year>
<article-title>Study on the developmental toxicity of combined artesunate and mefloquine antimalarial drugs on rats</article-title>. <source>Reprod Toxicol</source>. <volume>34</volume>(<issue>4</issue>):<fpage>658</fpage>&#x02013;<lpage>664</lpage>.<pub-id pub-id-type="pmid">23069110</pub-id></mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Briggs</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bain</surname><given-names>BJ</given-names></name></person-group>
<year>2017</year>
<chapter-title>Basic haematological techniques</chapter-title> In: <source>Dacie and Lewis practical haematology</source>. <edition>12th ed</edition>
<publisher-loc>New York (NY)</publisher-loc>: <publisher-name>Elsevier</publisher-name>; p. <fpage>18</fpage>&#x02013;<lpage>49</lpage>.</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caraballo</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Caraballo</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rodriguez-Acosta</surname><given-names>A</given-names></name></person-group>
<year>2004</year>
<article-title>Preliminary assessment of medicinal plants used as antimalarials in the Southern of Venezuelan Amazon</article-title>. <source>Rev Soc Bras Med Trop</source>. <volume>37</volume>(<issue>2</issue>):<fpage>186</fpage>&#x02013;<lpage>188</lpage>.<pub-id pub-id-type="pmid">15094909</pub-id></mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaaib</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Queiroz</surname><given-names>EF</given-names></name>, <name name-style="western"><surname>Ndjoko</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Diallo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Hostettmann</surname><given-names>K</given-names></name></person-group>
<year>2003</year>
<article-title>Antifungal and antioxidant compounds from the root bark of <italic>Fagara zanthoxyloides</italic></article-title>. <source>Planta Med</source>. <volume>69</volume>(<issue>4</issue>):<fpage>316</fpage>&#x02013;<lpage>320</lpage>.<pub-id pub-id-type="pmid">12709897</pub-id></mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chandel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bagai</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Semwal</surname><given-names>RB</given-names></name>, <name name-style="western"><surname>Semwal</surname><given-names>DK</given-names></name></person-group>
<year>2015</year>
<article-title>Antiplasmodial activity of aqueous extract of <italic>Berberis aristata</italic> roots against <italic>Plasmodium berghei</italic>-infected BALB/c mice</article-title>. <source>Pharm Biol</source>. <volume>53</volume>(<issue>12</issue>):<fpage>1735</fpage>&#x02013;<lpage>1740</lpage>.<pub-id pub-id-type="pmid">25858288</pub-id></mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clark</surname><given-names>RL</given-names></name></person-group>
<year>2009</year>
<article-title>Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester</article-title>. <source>Reprod Toxicol</source>. <volume>28</volume>(<issue>3</issue>):<fpage>285</fpage>&#x02013;<lpage>296</lpage>.<pub-id pub-id-type="pmid">19447170</pub-id></mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dias</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Vieira</surname><given-names>JLF</given-names></name>, <name name-style="western"><surname>Cabral</surname><given-names>BDC</given-names></name>, <name name-style="western"><surname>da Silva</surname><given-names>IRP</given-names></name>, <name name-style="western"><surname>Brasil</surname><given-names>LMBF</given-names></name>, <name name-style="western"><surname>Ara&#x000fa;jo</surname><given-names>EDC</given-names></name>, <name name-style="western"><surname>de Andrade</surname><given-names>MA</given-names></name></person-group>
<year>2016</year>
<article-title>Lipid profile of children with malaria by <italic>Plasmodium vivax</italic></article-title>. <source>J Trop Med</source>. <volume>2016</volume>:<fpage>9052612</fpage>.<pub-id pub-id-type="pmid">28050172</pub-id></mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dkhil</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Alazzouni</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Al-Quraishy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al-Shamrany</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Alazzouni</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Lubbad</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Al-Shaebi</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Taib</surname><given-names>NT</given-names></name></person-group>
<year>2015a</year>
<article-title>Protective effect of berberine chloride on <italic>Plasmodium chabaudi</italic>-induced hepatic tissue injury in mice</article-title>. <source>Saudi J Biol Sci</source>. <volume>22</volume>(<issue>5</issue>):<fpage>551</fpage>.<pub-id pub-id-type="pmid">26288557</pub-id></mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dkhil</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Alazzouni</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Al-Quraishy</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Al-Shamrany</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lubbad</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Al-Shaebi</surname><given-names>EM</given-names></name>, <name name-style="western"><surname>Taib</surname><given-names>NT</given-names></name></person-group>
<year>2015b</year>
<article-title>Berberine protects against murine malaria-induced spleen tissue damage</article-title>. <source>Biomed Res</source>. <volume>26</volume>(<issue>2</issue>):<fpage>333</fpage>&#x02013;<lpage>337</lpage>.</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dondorp</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Yi</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Phyo</surname><given-names>AP</given-names></name>, <name name-style="western"><surname>Tarning</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lwin</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Ariey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hanpithakpong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SJ</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2009</year>
<article-title>Artemisinin resistance in <italic>Plasmodium falciparum</italic> malaria</article-title>. <source>N Engl J Med</source>. <volume>361</volume>(<issue>5</issue>):<fpage>455</fpage>&#x02013;<lpage>467</lpage>.<pub-id pub-id-type="pmid">19641202</pub-id></mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dungdung</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jalawadi</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Yadav</surname><given-names>UP</given-names></name></person-group>
<year>2018</year>
<article-title>Study of serum lipid profile in <italic>Plasmodium falciparum</italic> malaria</article-title>. <source>Int J Res Med Sci</source>. <volume>6</volume>(<issue>11</issue>):<fpage>3673</fpage>&#x02013;<lpage>3677</lpage>.</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Dakdoky</surname><given-names>MI</given-names></name></person-group>
<year>2009</year>
<article-title>Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy</article-title>. <source>Food Chem Toxicol</source>. <volume>47</volume>(<issue>7</issue>):<fpage>1437</fpage>&#x02013;<lpage>1441</lpage>.<pub-id pub-id-type="pmid">19332101</pub-id></mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elujoba</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Odeleye</surname><given-names>OM</given-names></name>, <name name-style="western"><surname>Ogunyemi</surname><given-names>CM</given-names></name></person-group>
<year>2005</year>
<article-title>Traditional medicine development for medical and dental primary health care delivery system in Africa</article-title>. <source>AJTCAM</source>. <volume>2</volume>(<issue>1</issue>):<fpage>46</fpage>&#x02013;<lpage>61</lpage>.</mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Enechi</surname><given-names>OC</given-names></name>, <name name-style="western"><surname>Ugwu</surname><given-names>OPC</given-names></name></person-group>
<year>2013</year>
<article-title>Histopathological studies of liver function in rats fed on Ginger Lily corn meal</article-title>. <source>Mintage J Pharm Med Sci</source>. <volume>2</volume>:<fpage>55</fpage>&#x02013;<lpage>58</lpage>.</mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erhart</surname><given-names>LM</given-names></name>, <name name-style="western"><surname>Yingyuen</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Chuanak</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Buathong</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Laoboonchai</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Meshnick</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Gasser</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Wongsrichanalai</surname><given-names>C</given-names></name></person-group>
<year>2004</year>
<article-title>Hematologic and clinical indices of malaria in a semi-immune population of western Thailand</article-title>. <source>Am J Trop Med Hyg</source>. <volume>70</volume>(<issue>1</issue>):<fpage>8</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">14971691</pub-id></mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Esan</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Omisakin</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Titilayo</surname><given-names>OE</given-names></name>, <name name-style="western"><surname>Fasakin</surname><given-names>KA</given-names></name></person-group>
<year>2014</year>
<article-title>Gender difference on stress induced by malaria parasite infection and effect of anti-malaria drug on stress index</article-title>. <source>Am J Biomed Res</source>. <volume>2</volume>:<fpage>42</fpage>&#x02013;<lpage>46</lpage>.</mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gansane</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sanon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Quattara</surname><given-names>PL</given-names></name>, <name name-style="western"><surname>Hutter</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ollivier</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Azas</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Traore</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Traore</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Guissou</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Nebie</surname><given-names>I</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2010</year>
<article-title>Antiplasmodial activity and cytotoxicity of semi purified fraction from <italic>Zanthoxylum zanthoxyloides</italic> Lam bark of Trunk</article-title>. <source>Int J Pharmacol</source>. <volume>6</volume>(<issue>6</issue>):<fpage>921</fpage>&#x02013;<lpage>925</lpage>.</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>George</surname><given-names>BO</given-names></name>, <name name-style="western"><surname>Okpoghono</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Osioma</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Aina</surname><given-names>OO</given-names></name></person-group>
<year>2012</year>
<article-title>Changes in oxidative indices in <italic>Plasmodium berghei</italic> infected mice treated with aqueous extract of <italic>Aframomum sceptrum</italic></article-title>. <source>FS</source>. <volume>2</volume>:<fpage>6</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanscheid</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Egan</surname><given-names>TJ</given-names></name>, <name name-style="western"><surname>Grobusch</surname><given-names>MP</given-names></name></person-group>
<year>2007</year>
<article-title>Haemozoin: from melatonin pigment to drug target, diagnostic tool, and immune modulator</article-title>. <source>Lancet Infect Dis</source>. <volume>7</volume>(<issue>10</issue>):<fpage>675</fpage>&#x02013;<lpage>685</lpage>.<pub-id pub-id-type="pmid">17897610</pub-id></mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Harborne</surname><given-names>JB</given-names></name></person-group>
<year>1998</year>
<source>Textbook of phytochemical method</source>. <edition>3rd ed</edition>
<publisher-loc>London (UK)</publisher-loc>: <publisher-name>Chapman and Hall Ltd</publisher-name>.</mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holz</surname><given-names>J</given-names></name></person-group>
<year>1977</year>
<article-title>Lipids and the malaria parasite</article-title>. <source>Bull World Health Organ</source>. <volume>55</volume>(<issue>2&#x02013;3</issue>):<fpage>237</fpage>&#x02013;<lpage>248</lpage>.<pub-id pub-id-type="pmid">412602</pub-id></mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honig</surname><given-names>GR</given-names></name>, <name name-style="western"><surname>Farnsworth</surname><given-names>NR</given-names></name>, <name name-style="western"><surname>Ferenc</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Vida</surname><given-names>LN</given-names></name></person-group>
<year>1975</year>
<article-title>Evaluation of <italic>Fagara zanthoxyloides</italic> root extract in sickle cell anemia blood <italic>in vitro</italic></article-title>. <source>Lloydia</source>. <volume>38</volume>(<issue>5</issue>):<fpage>387</fpage>&#x02013;<lpage>390</lpage>.<pub-id pub-id-type="pmid">1202311</pub-id></mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ifeanyichukwu</surname><given-names>MO</given-names></name>, <name name-style="western"><surname>Esan</surname><given-names>A</given-names></name></person-group>
<year>2014</year>
<article-title>Evaluation of blood cells and platelets in <italic>Plasmodium falciparum</italic> malaria infected individuals</article-title>. <source>Int J Hematol Disord</source>. <volume>1</volume>:<fpage>49</fpage>&#x02013;<lpage>54</lpage>.</mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ikekpeazu</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Neboh</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Aguchime</surname><given-names>NC</given-names></name>, <name name-style="western"><surname>Maduka</surname><given-names>IC</given-names></name>, <name name-style="western"><surname>Anyanwu</surname><given-names>EG</given-names></name></person-group>
<year>2010</year>
<article-title>Malaria parasitaemia: effect on serum sodium and potassium levels</article-title>. <source>Biol Med</source>. <volume>2</volume>:<fpage>20</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="conference"><person-group person-group-type="author"><name name-style="western"><surname>Isaac</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Abah</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Akpan</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ekaette</surname><given-names>IU</given-names></name></person-group>
<year>2013</year> Hematological properties of different breeds and sexes of rabbits. Proceedings of the 18th Annual Conference of Animal Science Association of Nigeria. p. <fpage>24</fpage>&#x02013;<lpage>27</lpage>.</mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Iwasa</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Wataya</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>DU</given-names></name></person-group>
<year>1998</year>
<article-title>Antimalarial activity and structure activity relationships of protoberberine alkaloids</article-title>. <source>Eur J Med Chem</source>. <volume>33</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>69</lpage>.</mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jasani</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Sancheti</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Gheewala</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Bhuva</surname><given-names>KV</given-names></name>, <name name-style="western"><surname>Doctor</surname><given-names>VS</given-names></name>, <name name-style="western"><surname>Vacchani</surname><given-names>AB</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>VR</given-names></name>, <name name-style="western"><surname>Dhairya</surname><given-names>L</given-names></name></person-group>
<year>2012</year>
<article-title>Association of the electrolyte disturbances (Na<sup>+</sup>, K<sup>+</sup>) with the type and severity of the malarial parasitic infection</article-title>. <source>J Clin Diagn Res</source>. <volume>6</volume>:<fpage>678</fpage>&#x02013;<lpage>681</lpage>.</mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kassim</surname><given-names>OO</given-names></name>, <name name-style="western"><surname>Loyevsky</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Geall</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Amonoo</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Gordeuk</surname><given-names>VR</given-names></name></person-group>
<year>2005</year>
<article-title>Effects of root extracts of <italic>Fagara zanthoxyloides</italic> on the <italic>in vitro</italic> growth and stage distribution of <italic>Plasmodium falciparum</italic></article-title>. <source>Antimicrob Agents Ch</source>. <volume>49</volume>(<issue>1</issue>):<fpage>264</fpage>&#x02013;<lpage>268</lpage>.</mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khaomek</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ichino</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Ishiyama</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sekiguchi</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Namatame</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ruangrungsi</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Saifah</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Kiyohara</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Otoguro</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Omura</surname><given-names>S</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2008</year>
<article-title><italic>In vitro</italic> antimalarial activity of prenylated flavonoids from <italic>Erythrina fusca</italic></article-title>. <source>J Nat Med</source>. <volume>62</volume>(<issue>2</issue>):<fpage>217</fpage>&#x02013;<lpage>220</lpage>.<pub-id pub-id-type="pmid">18404327</pub-id></mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khovidhunkit</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>M-S</given-names></name>, <name name-style="western"><surname>Memon</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Shigenaga</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Moser</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Feingold</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Grunfeld</surname><given-names>C</given-names></name></person-group>
<year>2004</year>
<article-title>Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host</article-title>. <source>J Lipid Res</source>. <volume>45</volume>(<issue>7</issue>):<fpage>1169</fpage>&#x02013;<lpage>1196</lpage>.<pub-id pub-id-type="pmid">15102878</pub-id></mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kings</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Wootton</surname><given-names>IDP</given-names></name></person-group>
<year>1959</year>
<source>Microanalysis in medical biochemistry</source>. <publisher-loc>London (UK)</publisher-loc>: <publisher-name>J and A Churchill Ltd</publisher-name>.</mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kiru</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Bala</surname><given-names>RK</given-names></name>, <name name-style="western"><surname>Abdulazeez</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Adam</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Suleiman</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Shamsu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Abdulkadir</surname><given-names>ML</given-names></name></person-group>
<year>2018</year>
<article-title>Lipid profile and electrolyte level in malaria patients attending Muhammadu Abdullahi Wuse Specialist Hospital, Kano State</article-title>. <source>JOCAMR</source>. <volume>5</volume>(<issue>4</issue>):<fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koffuor</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Dadzeasah</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Sam</surname><given-names>GH</given-names></name></person-group>
<year>2012</year>
<article-title>Hematopoietic effect of an ethanolic leaf extract of <italic>Ipomoea involucrata</italic> P. Beauv in phlebotomized New Zealand white rabbits</article-title>. <source>J Med Biomed Sci</source>. <volume>1</volume>:<fpage>10</fpage>&#x02013;<lpage>16</lpage>.</mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chandra</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Joel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lipin</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Arun</surname><given-names>KTV</given-names></name>, <name name-style="western"><surname>Thankamani</surname><given-names>V</given-names></name></person-group>
<year>2011</year>
<article-title>Ethnobotanical and pharmacological study of <italic>Alstonia</italic> (Apocynaceae) &#x02013; a review</article-title>. <source>J Pharm Sci Res</source>. <volume>3</volume>:<fpage>1394</fpage>&#x02013;<lpage>1403</lpage>.</mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Grondard</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Couprie</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Desoize</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Comoe</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Jardillier</surname><given-names>J-C</given-names></name>, <name name-style="western"><surname>Riou</surname><given-names>J-F</given-names></name></person-group>
<year>1993</year>
<article-title>The antileukemic alkaloid, fagaronine is an inhibitor of DNA topoisomerases I and II</article-title>. <source>Biochem Pharmacol</source>. <volume>46</volume>(<issue>8</issue>):<fpage>1403</fpage>&#x02013;<lpage>1412</lpage>.<pub-id pub-id-type="pmid">8240389</pub-id></mixed-citation></ref><ref id="CIT0049"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawal</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shittu</surname><given-names>OK</given-names></name>, <name name-style="western"><surname>Kabiru</surname><given-names>AY</given-names></name>, <name name-style="western"><surname>Jigam</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Umar</surname><given-names>MB</given-names></name>, <name name-style="western"><surname>Berinyuy</surname><given-names>EB</given-names></name>, <name name-style="western"><surname>Alozieuwa</surname><given-names>BU</given-names></name></person-group>
<year>2015</year>
<article-title>Potential antimalarials from African natural products: a review</article-title>. <source>J Intercult Ethnopharmacol</source>. <volume>4</volume>(<issue>4</issue>):<fpage>318</fpage>&#x02013;<lpage>343</lpage>.<pub-id pub-id-type="pmid">26649238</pub-id></mixed-citation></ref><ref id="CIT0050"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lorke</surname><given-names>D</given-names></name></person-group>
<year>1983</year>
<article-title>A new approach to practical acute toxicity testing</article-title>. <source>Arch Toxicol</source>. <volume>54</volume>(<issue>4</issue>):<fpage>275</fpage>&#x02013;<lpage>287</lpage>.<pub-id pub-id-type="pmid">6667118</pub-id></mixed-citation></ref><ref id="CIT0051"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lun</surname><given-names>ZR</given-names></name>, <name name-style="western"><surname>Ferreira</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>LC</given-names></name></person-group>
<year>2014</year>
<article-title>Artemisinin resistance in <italic>Plasmodium falciparum</italic></article-title>. <source>Lancet Infect Dis</source>. <volume>14</volume>(<issue>6</issue>):<fpage>450</fpage>&#x02013;<lpage>451</lpage>.<pub-id pub-id-type="pmid">24849723</pub-id></mixed-citation></ref><ref id="CIT0052"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Che</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>Y</given-names></name></person-group>
<year>2018</year>
<article-title>Toxicity and related mechanisms of dihydroartemisinin on porcine oocyte maturation <italic>in vitro</italic></article-title>. <source>Toxicol Appl Pharmacol</source>. <volume>341</volume>:<fpage>8</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">29309768</pub-id></mixed-citation></ref><ref id="CIT0053"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luzzi</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Peto</surname><given-names>T</given-names></name></person-group>
<year>1993</year>
<article-title>Adverse effects of antimalarials. An update</article-title>. <source>Drug Saf</source>. <volume>8</volume>(<issue>4</issue>):<fpage>295</fpage>&#x02013;<lpage>311</lpage>.<pub-id pub-id-type="pmid">8481216</pub-id></mixed-citation></ref><ref id="CIT0054"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maximin</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Ioset</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Ioset</surname><given-names>KN</given-names></name>, <name name-style="western"><surname>Diallo</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Mauel</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hostettemann</surname><given-names>K</given-names></name></person-group>
<year>2007</year>
<article-title>Antileishmanial activities associated with plants used in the Malian traditional medicine</article-title>. <source>J Ethnopharmacol</source>. <volume>110</volume>:<fpage>99</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">17097842</pub-id></mixed-citation></ref><ref id="CIT0055"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGready</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thwai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Samuel</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>White</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Nosten</surname><given-names>F</given-names></name></person-group>
<year>2002</year>
<article-title>The effects of quinine and chloroquine trimester of pregnancy antimalarial treatments in the first centered around the potential for auditory nerve damage</article-title>. <source>Trans R Soc Trop Med Hyg</source>. <volume>96</volume>:<fpage>180</fpage>&#x02013;<lpage>184</lpage>.<pub-id pub-id-type="pmid">12055810</pub-id></mixed-citation></ref><ref id="CIT0056"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Medhi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Deka</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Bhau</surname><given-names>BS</given-names></name></person-group>
<year>2013</year>
<article-title>The Genus <italic>Zanthoxylum</italic> &#x02013; a stockpile of biological and ethnomedicinal properties</article-title>. <source>Open Access Sci Rep</source>. <volume>2</volume>(<issue>3</issue>):<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="CIT0057"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Misra</surname><given-names>LN</given-names></name>, <name name-style="western"><surname>Wouatsa</surname><given-names>NA</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Venkatesh</surname><given-names>KR</given-names></name>, <name name-style="western"><surname>Tchoumbougnang</surname><given-names>F</given-names></name></person-group>
<year>2013</year>
<article-title>Antibacterial, cytotoxic activities and chemical composition of fruits of two Cameroonian <italic>Zanthoxylum</italic> species</article-title>. <source>J Ethnopharmacol</source>. <volume>148</volume>(<issue>1</issue>):<fpage>74</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">23567034</pub-id></mixed-citation></ref><ref id="CIT0058"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Momoh</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Longe</surname><given-names>AO</given-names></name></person-group>
<year>2014</year>
<article-title><italic>In-vivo</italic> anti-plasmodial and <italic>in-vitro</italic> anti-oxidant activity of ethanol leaf extract of <italic>Alstonia boonei</italic> (Ewe Ahun) and its effect on some biochemical parameters in Swiss albino mice infected with <italic>Plasmodium berghei</italic> NK 45</article-title>. <source>Eur Sci J</source>. <volume>10</volume>:<fpage>68</fpage>&#x02013;<lpage>82</lpage>.</mixed-citation></ref><ref id="CIT0059"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noori</surname><given-names>S</given-names></name></person-group>
<year>2012</year>
<article-title>An overview of oxidative stress and anti-oxidant defensive system</article-title>. *<source>Open Access Sci Rep</source>. <volume>1</volume>(<issue>8</issue>):<fpage>1</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="CIT0060"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nuwaha</surname><given-names>F</given-names></name></person-group>
<year>2001</year>
<article-title>The challenge of chloroquine-resistant malaria in sub-Saharan Africa</article-title>. <source>Health Policy Plan</source>. <volume>16</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>12</lpage>.</mixed-citation></ref><ref id="CIT0061"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Odeghe</surname><given-names>OB</given-names></name>, <name name-style="western"><surname>Uwakwe</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Monago</surname><given-names>CC</given-names></name></person-group>
<year>2012</year>
<article-title>Some biochemical and hematological studies on the methanolic extract of <italic>Anthocleista grandiflora</italic> stem bark</article-title>. <source>IJAST</source>. <volume>2</volume>:<fpage>58</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="CIT0062"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogbadoyi</surname><given-names>EO</given-names></name>, <name name-style="western"><surname>Gabi</surname><given-names>B</given-names></name></person-group>
<year>2015</year>
<article-title>Assessment of renal function in malaria patients in Minna, North Central Nigeria</article-title>. <source>Afr J Infect Dis</source>. <volume>1</volume>:<fpage>57</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="CIT0063"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogbuehi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Adikwu</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Oputiri</surname><given-names>D</given-names></name></person-group>
<year>2014</year>
<article-title>Effect of <italic>Acalypha wilkesiana</italic> MuellArg leaf extract on the oxidative indices, liver enzymes and liver integrity of rats infected with <italic>Plasmodium berghei</italic></article-title>. <source>BJPT</source>. <volume>5</volume>(<issue>2</issue>):<fpage>68</fpage>&#x02013;<lpage>74</lpage>.</mixed-citation></ref><ref id="CIT0064"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogwal-Okeng</surname><given-names>JW</given-names></name>, <name name-style="western"><surname>Obua</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Anokbonggo</surname><given-names>WW</given-names></name></person-group>
<year>2003</year>
<article-title>Acute toxicity effects of the methanolic extract of <italic>Fagara zanthoxyloides</italic> (Lam.) root-bark</article-title>. <source>Afr Health Sci</source>. <volume>3</volume>(<issue>3</issue>):<fpage>124</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">14676717</pub-id></mixed-citation></ref><ref id="CIT0066"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okeke</surname><given-names>MI</given-names></name>, <name name-style="western"><surname>Iroegbu</surname><given-names>CU</given-names></name>, <name name-style="western"><surname>Eze</surname><given-names>EN</given-names></name>, <name name-style="western"><surname>Okoli</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Esimone</surname><given-names>CO</given-names></name></person-group>
<year>2001</year>
<article-title>Evaluation of extracts of the root of <italic>Landolphia owerrience</italic> for antibacterial activity</article-title>. <source>J Ethnopharmacol</source>. <volume>78</volume>(<issue>2&#x02013;3</issue>):<fpage>119</fpage>&#x02013;<lpage>127</lpage>.<pub-id pub-id-type="pmid">11694355</pub-id></mixed-citation></ref><ref id="CIT0067"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oriowo</surname><given-names>MA</given-names></name></person-group>
<year>1982</year>
<article-title>Anti-inflammatory activity of piperonyl-4-acrylic isobutyl amide, an extractive from <italic>Zanthoxylum zanthoxyloides</italic></article-title>. <source>Planta Med</source>. <volume>44</volume>(<issue>1</issue>):<fpage>54</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">7063561</pub-id></mixed-citation></ref><ref id="CIT0068"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Osei-Bimpong</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Burthem</surname><given-names>J</given-names></name></person-group>
<year>2017</year>
<chapter-title>Supplementary techniques including blood parasite diagnosis</chapter-title> In: <source>Dacie and Lewis practical haematology</source>. <edition>12th ed</edition>
<publisher-loc>New York (NY)</publisher-loc>: <publisher-name>Elsevier</publisher-name>; p. <fpage>101</fpage>&#x02013;<lpage>107</lpage>.</mixed-citation></ref><ref id="CIT0069"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Osho</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Fayemi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Adetunji</surname><given-names>T</given-names></name></person-group>
<year>2011</year>
<article-title><italic>In-vitro</italic> screening of some selected Nigerian medicinal plants (<italic>Fagara zanthoxyloides, Vernonia amygdalina, Prosopis africana</italic> and <italic>Azadirachta indica</italic>) for antibacterial activity</article-title>. <source>Adv Biores</source>. <volume>2</volume>:<fpage>190</fpage>&#x02013;<lpage>195</lpage>.</mixed-citation></ref><ref id="CIT0070"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ouattara</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jansen</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Angenot</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Guissou</surname><given-names>IP</given-names></name>, <name name-style="western"><surname>Frederich</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Fondu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Tits</surname><given-names>M</given-names></name></person-group>
<year>2009</year>
<article-title>Antisickling properties of divanilloylquinic acids isolated from <italic>Fagara zanthoxyloides</italic> Lam. (Rutaceae)</article-title>. <source>Phytomedicine</source>. <volume>16</volume>(<issue>2&#x02013;3</issue>):<fpage>125</fpage>&#x02013;<lpage>129</lpage>.<pub-id pub-id-type="pmid">19110407</pub-id></mixed-citation></ref><ref id="CIT0071"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oyedapo</surname><given-names>OO</given-names></name>, <name name-style="western"><surname>Famurewa</surname><given-names>AJ</given-names></name></person-group>
<year>1995</year>
<article-title>Antiprotease and membrane stabilizing activities of extracts <italic>of Fagara zanthoxyloides, Olax subscorpioides</italic> and <italic>Tetrapleura tetraptera</italic></article-title>. <source>Int J Pharmacogn</source>. <volume>33</volume>(<issue>1</issue>):<fpage>65</fpage>&#x02013;<lpage>69</lpage>.</mixed-citation></ref><ref id="CIT0072"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parida</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Kalita</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yadav</surname><given-names>RNS</given-names></name>, <name name-style="western"><surname>Shankar</surname><given-names>B</given-names></name></person-group>
<year>2014</year>
<article-title>Homology modeling and docking studies of <italic>Plasmodium falciparum</italic> telomerase reverse transcriptase with berberine and some of its derivatives</article-title>. <source>Bangladesh J Pharmacol</source>. <volume>9</volume>(<issue>1</issue>):<fpage>96</fpage>&#x02013;<lpage>104</lpage>.</mixed-citation></ref><ref id="CIT0073"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peters</surname><given-names>W</given-names></name></person-group>
<year>1965</year>
<article-title>Drug resistance in <italic>Plasmodium berghei</italic> Vincke and Lips, 1948. I. Chloroquine resistance</article-title>. <source>Exp Parasitol</source>. <volume>17</volume>(<issue>1</issue>):<fpage>80</fpage>&#x02013;<lpage>89</lpage>.<pub-id pub-id-type="pmid">5843289</pub-id></mixed-citation></ref><ref id="CIT0074"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peto</surname><given-names>TEA</given-names></name></person-group>
<year>1989</year>
<article-title>Toxicity of antimalarial drugs</article-title>. <source>J R Soc Med</source>. <volume>82</volume>(<issue>S17</issue>):<fpage>30</fpage>&#x02013;<lpage>33</lpage>.</mixed-citation></ref><ref id="CIT0075"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prado</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Michel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tillequin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Koch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Pfeiffer</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Pierr&#x000e9;</surname><given-names>A</given-names></name>, <name name-style="western"><surname>L&#x000e9;once</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Colson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Baldeyrou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Lansiaux</surname><given-names>A</given-names></name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2004</year>
<article-title>Synthesis and cytotoxic activity of benzo phenanthrolines analogues of nitidine and fagaronine</article-title>. <source>Bioorg Med Chem</source>. <volume>12</volume>(<issue>14</issue>):<fpage>3943</fpage>&#x02013;<lpage>3953</lpage>.<pub-id pub-id-type="pmid">15210161</pub-id></mixed-citation></ref><ref id="CIT0076"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>National Academy of Sciences [NAS].</collab></person-group>
<year>2011</year>
<source>Guide for the care and use of laboratory animals, 8th Ed. Institute for Laboratory Animal Research, Division on Earth and Life Studies</source>. <publisher-loc>Washington (DC)</publisher-loc>: <publisher-name>National Academy of Sciences</publisher-name>.</mixed-citation></ref><ref id="CIT0077"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rahman</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Hosen</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Islam</surname><given-names>MMT</given-names></name>, <name name-style="western"><surname>Shekhar</surname><given-names>HU</given-names></name></person-group>
<year>2012</year>
<article-title>Oxidative stress and human health</article-title>. <source>ABB</source>. <volume>03</volume>(<issue>07</issue>):<fpage>997</fpage>&#x02013;<lpage>1019</lpage>.</mixed-citation></ref><ref id="CIT0078"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rogers</surname><given-names>WO</given-names></name>, <name name-style="western"><surname>Sem</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Tero</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Chim</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Muth</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Socheat</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ariey</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Wongsrichanalai</surname><given-names>C</given-names></name></person-group>
<year>2009</year>
<article-title>Failure of artesunate&#x02013;mefloquine combination therapy for uncomplicated <italic>Plasmodium falciparum</italic> malaria in Southern Cambodia</article-title>. <source>Malar J</source>. <volume>8</volume>:<fpage>10</fpage>&#x02013;<lpage>18</lpage>.<pub-id pub-id-type="pmid">19138388</pub-id></mixed-citation></ref><ref id="CIT0079"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Huskin</surname><given-names>AL</given-names></name>, <name name-style="western"><surname>Helenowski</surname><given-names>IB</given-names></name>, <name name-style="western"><surname>Rademaker</surname><given-names>AW</given-names></name></person-group>
<year>2007</year>
<article-title>Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome</article-title>. <source>Diabetes Care</source>. <volume>30</volume>(<issue>8</issue>):<fpage>1945</fpage>&#x02013;<lpage>1951</lpage>.<pub-id pub-id-type="pmid">17483155</pub-id></mixed-citation></ref><ref id="CIT0080"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sandro</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Danilo</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>AQ</given-names></name>, <name name-style="western"><surname>Michelli</surname><given-names>ES</given-names></name>, <name name-style="western"><surname>Ana Carolina</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Paula</surname><given-names>SO</given-names></name>, <name name-style="western"><surname>Thyago</surname><given-names>CV</given-names></name>, <name name-style="western"><surname>Maria</surname><given-names>FD</given-names></name>, <name name-style="western"><surname>Michael</surname><given-names>DG</given-names></name></person-group>
<year>2012</year>
<article-title>Oxidative stress in malaria</article-title>. <source>Int J Mol Sci</source>. <volume>13</volume>:<fpage>16346</fpage>&#x02013;<lpage>16372</lpage>.<pub-id pub-id-type="pmid">23208374</pub-id></mixed-citation></ref><ref id="CIT0081"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saxena</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Pant</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>DC</given-names></name>, <name name-style="western"><surname>Bhakuni</surname><given-names>RS</given-names></name></person-group>
<year>2003</year>
<article-title>Antimalarial agents from plant sources</article-title>. <source>Curr Sci</source>. <volume>85</volume>:<fpage>1314</fpage>&#x02013;<lpage>1329</lpage>.</mixed-citation></ref><ref id="CIT0082"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Silikas</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Mccall</surname><given-names>DLC</given-names></name>, <name name-style="western"><surname>Sharples</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Watkins</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Waigh</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Barber</surname><given-names>J</given-names></name></person-group>
<year>1996</year>
<article-title>The antimalarial activity of berberine and some synthetic analogues</article-title>. <source>Pharm Pharmacol Commun</source>. <volume>2</volume>:<fpage>55</fpage>&#x02013;<lpage>58</lpage>.</mixed-citation></ref><ref id="CIT0083"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sofowora</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Isaacs</surname><given-names>WA</given-names></name></person-group>
<year>1971</year>
<article-title>Reversal of sickling and crenation in erythrocytes by the root extract of <italic>Fagara zanthoxyloides</italic></article-title>. <source>Lloydia</source>. <volume>34</volume>(<issue>4</issue>):<fpage>383</fpage>&#x02013;<lpage>385</lpage>.<pub-id pub-id-type="pmid">4950991</pub-id></mixed-citation></ref><ref id="CIT0084"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sofowora</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Isaac-Sodeye</surname><given-names>WA</given-names></name>, <name name-style="western"><surname>Ogunkoya</surname><given-names>LO</given-names></name></person-group>
<year>1975</year>
<article-title>Isolation and characterisation of an antisickling agent from <italic>Fagara zanthoxyloides</italic> root</article-title>. <source>Lloydia</source>. <volume>38</volume>(<issue>2</issue>):<fpage>169</fpage>&#x02013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">1134214</pub-id></mixed-citation></ref><ref id="CIT0085"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sriwilaijareon</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Petmitr</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mutirangura</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ponglikitmongkol</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wilairat</surname><given-names>P</given-names></name></person-group>
<year>2002</year>
<article-title>Stage specificity of <italic>Plasmodium falciparum</italic> telomerase and its inhibition by berberine</article-title>. <source>Parasitol Int</source>. <volume>51</volume>(<issue>1</issue>):<fpage>99</fpage>&#x02013;<lpage>103</lpage>.<pub-id pub-id-type="pmid">11880232</pub-id></mixed-citation></ref><ref id="CIT0086"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Stooper</surname><given-names>MC</given-names></name></person-group>
<year>2015</year>
<source>Electrolytes</source>. <publisher-loc>Mission Viejo (CA)</publisher-loc>: <publisher-name>William C. Shiel Publication</publisher-name>; p. <fpage>34</fpage>&#x02013;<lpage>50</lpage>.</mixed-citation></ref><ref id="CIT0087"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suresh</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haldar</surname><given-names>K</given-names></name></person-group>
<year>2018</year>
<article-title>Mechanisms of artemisinin resistance in <italic>Plasmodium falciparum</italic> malaria</article-title>. <source>Curr Opin Pharmacol</source>. <volume>42</volume>:<fpage>46</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">30077118</pub-id></mixed-citation></ref><ref id="CIT0088"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taiwo</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>HX</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SF</given-names></name></person-group>
<year>1999</year>
<article-title>Antibacterial activities of extracts from Nigerian chewing sticks</article-title>. <source>Phytother Res</source>. <volume>13</volume>(<issue>8</issue>):<fpage>675</fpage>&#x02013;<lpage>679</lpage>.<pub-id pub-id-type="pmid">10594937</pub-id></mixed-citation></ref><ref id="CIT0089"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takanishi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Saiomoto</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kabasawa</surname><given-names>T</given-names></name></person-group>
<year>1999</year>
<article-title>Structural considerations of NK109, an antitumor benzo phenanthridine alkaloid</article-title>. <source>J Nat Prod</source>. <volume>62</volume>:<fpage>864</fpage>&#x02013;<lpage>867</lpage>.<pub-id pub-id-type="pmid">10395504</pub-id></mixed-citation></ref><ref id="CIT0090"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trampuz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jereb</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Muzlovi</surname><given-names>CI</given-names></name>, <name name-style="western"><surname>Prabhu</surname><given-names>RM</given-names></name></person-group>
<year>2003</year>
<article-title>Clinical review: severe malaria</article-title>. <source>Crit Care</source>. <volume>7</volume>(<issue>4</issue>):<fpage>315</fpage>&#x02013;<lpage>323</lpage>.<pub-id pub-id-type="pmid">12930555</pub-id></mixed-citation></ref><ref id="CIT0091"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Trease</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Evans</surname><given-names>WC</given-names></name></person-group>
<year>1989</year>
<source>Pharmacognosy</source>. <edition>13th ed</edition>
<publisher-loc>London (UK)</publisher-loc>: <publisher-name>Bailliere Tindall Books Publishers</publisher-name>; p. <fpage>1</fpage>&#x02013;<lpage>105</lpage>.</mixed-citation></ref><ref id="CIT0093"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugwu</surname><given-names>OPC</given-names></name>, <name name-style="western"><surname>Nwodo</surname><given-names>OFC</given-names></name>, <name name-style="western"><surname>Joshua</surname><given-names>PE</given-names></name>, <name name-style="western"><surname>Odo</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Bawa</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ossai</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Adonu</surname><given-names>CC</given-names></name></person-group>
<year>2013</year>
<article-title>Anti-malaria and hematological analyses of ethanol leaf extract of <italic>Moringa oleifera</italic> on malaria infected mice</article-title>. <source>Int J Pharm Biol Sci</source>. <volume>3</volume>:<fpage>360</fpage>&#x02013;<lpage>371</lpage>.</mixed-citation></ref><ref id="CIT0094"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ugwuene</surname><given-names>MC</given-names></name></person-group>
<year>2011</year>
<article-title>Effect of dietary palm kernel meal for maize on the haematological and serum chemistry of broiler Turkey</article-title>. <source>Nig J Anim Sci</source>. <volume>13</volume>:<fpage>93</fpage>&#x02013;<lpage>103</lpage>.</mixed-citation></ref><ref id="CIT0095"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Wolfswinkel</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Hesselink</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Zietse</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Hoorn</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>van Genderen</surname><given-names>P</given-names></name></person-group>
<year>2010</year>
<article-title>Hyponatraemia in imported malaria is common and associated with disease severity</article-title>. <source>Malar J</source>. <volume>9</volume>(<issue>1</issue>):<fpage>140</fpage>.<pub-id pub-id-type="pmid">20497587</pub-id></mixed-citation></ref><ref id="CIT0096"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Visser</surname><given-names>BJ</given-names></name>, <name name-style="western"><surname>Wieten</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Nagel</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Grobusch</surname><given-names>MP</given-names></name></person-group>
<year>2013</year>
<article-title>Serum lipids and lipoproteins in malaria-a systematic review and meta-analysis</article-title>. <source>Malar J</source>. <volume>12</volume>:<fpage>442</fpage>&#x02013;<lpage>454</lpage>.<pub-id pub-id-type="pmid">24314058</pub-id></mixed-citation></ref><ref id="CIT0097"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallin</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Rosengren</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Shertzer</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Camejo</surname><given-names>G</given-names></name></person-group>
<year>1993</year>
<article-title>Lipoprotein oxidation and measurement of TBARS formation in single microlitre plate; its use for evaluation of antioxidants</article-title>. <source>Anal Biochem</source>. <volume>208</volume>(<issue>1</issue>):<fpage>10</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">8434778</pub-id></mixed-citation></ref><ref id="CIT0098"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization [WHO].</collab></person-group>
<year>2016a</year>
<source>World malaria report</source>. <publisher-loc>Geneva (Switzerland)</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="CIT0099"><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization [WHO].</collab></person-group>
<year>2016b</year>
<source>Malaria microscopy quality assurance manual, Version 2</source>. <publisher-loc>Geneva (Switzerland)</publisher-loc>: <publisher-name>World Health Organization</publisher-name>.</mixed-citation></ref><ref id="CIT0100"><mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization [WHO].</collab></person-group>
<year>2017</year> World Malaria Report [accessed 2018 Jul 14]. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/news-room/fact-sheets/detail/malaria/2017">www.who.int/news-room/fact-sheets/detail/malaria/2017</ext-link>.</mixed-citation></ref><ref id="CIT0101"><mixed-citation publication-type="web"><person-group person-group-type="author"><collab>World Health Organization [WHO].</collab></person-group>
<year>2018</year> World Malaria Report [accessed 2018 Jul 14]. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/news-room/fact-sheets/detail/malaria/2018">www.who.int/news-room/fact-sheets/detail/malaria/2018</ext-link>.</mixed-citation></ref><ref id="CIT0102"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Waterman</surname><given-names>DF</given-names></name>, <name name-style="western"><surname>Hemken</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Harmon</surname><given-names>RJ</given-names></name></person-group>
<year>1991</year>
<article-title>Effects of copper status on neutrophil function, superoxide dismutase and copper distribution in steers</article-title>. <source>J Diary Sci</source>. <volume>74</volume>(<issue>9</issue>):<fpage>3078</fpage>&#x02013;<lpage>3082</lpage>.</mixed-citation></ref><ref id="CIT0103"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ynalvez</surname><given-names>RA</given-names></name>, <name name-style="western"><surname>Cardenas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Addo</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Adukpo</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Dadson</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Addo</surname><given-names>MA</given-names></name></person-group>
<year>2012</year>
<article-title>Evaluation of the antimicrobial activity of <italic>Zantholum zanthoxyloides</italic> root bark extracts</article-title>. <source>Res J Med Plant</source>. <volume>6</volume>(<issue>2</issue>):<fpage>149</fpage>&#x02013;<lpage>159</lpage>.</mixed-citation></ref></ref-list></back></article>